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Part T

Small Nuclear Ribonucleoproteins
Chapter 1

INTRODUCTION

Since the discovery (Tan and Kunkel, IO66; Mattioli and Peichlin,
1971; Sharp, et al., 1972) of human SLE autoantibodies directed against
RNA-protein complexes in eucaryotic nuclei, a great deal of interest has
been generated regarding both the relationships of antibody specificities
to disease and the biological roles of the recognized antigens. These
antibodies are some of the many autoantibody species which have been

described in systemic lupus erythematosus (SLE) as well as other rheimatic
disease conditions. A common feature of many of these reactivities is the
apparent nuclear localization of antigen. Study of the antibodies as well
as these antigens has led to formation of a particularly unique bridge
between clinical medicine and basic science questions in cellular biology
and metabolism.
The spectrum of diseases which present with antibodies directed
against cellular constituents is vast although certain features of these
conditions imply common aspects which may, furthermore, be of some
diagnostic use. Familial clustering and HLA associations (Grimet, et al.,
1971; Nies, et al., 1974; Kissmeyer-Nielsen, et al., 1975; Arnett and
Shulman 1.976; Goldberg, et al., 1976; Horn, et al., I07o qchur and

Carpenter 1993) have pointed to genetic factors which may relate to common
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etiologies or distinguish among certain of these diseases (libofsky, et
al., 1973). This group of diseases includes SLE, mixed connective tissue
disease (MCTP), scleroderma, Sjogren's syndrome, rheumatoid arthritis,
polymyositis, dermatomyositis, and overlap syndromes.
The observation of antinuclear antibodies was probably first reported
in the description of the LE cell (Hargraves, et al., 194P). This
phenomenon, thought to reflect phagocytosis of antibody coated nuclei by
polymorphonuclear leukocytes, has historically provided useful diagnostic
information. Three reports in 1957 (Holman and Kunkel, lf>'=^"'; Friou, et
al,, 1<^57; Holborrow, et al., 1057) utilized fluorescent antinuclear
antibody binding to demonstrate the presence of antinuclear components in
serum of patients with a variety of disorders. The report (Barnett 107-7)
of low antinuclear antibody titers in a significant proportion of normals
has suggested that the simple presence of such immunoglobulins may not be
pathological (in low titers). With increasingly sophisticated methods of
analysis, more detailed study of these autoantibodies has been carried out
resulting in the elucidation of better defined antigen-antibody systems as
disease markers and prognostic indicators.
Numerous autoantibody-antigen systems have been described in
considerable detail, the majority involving antibodies to nuclear
components. The indirect immunofluorescence technique has had very wide
use in analysis of such antibodies. Microscopic analysis has revealed
several distinguishable patterns of staining which have been shown to
correspond to different antigenic specificities (Tan ioo9>. The diffuse

nuclear staining which frequently characterizes anti-DNA antibo-dies differ

from speckled staining (typical of antibodies to certain saline extractable
nuclear antigens). Other patterns of staining include "rim," nucleolar.
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and

centromere/kineticore,

each

corresponding

to

distinct

antigenic

recognition patterns. TVo potential hazards in interpretation of the
indirect immunofluorescence test are losses of antigen during washing
procedures from the fixed cells and possible denaturation effects capable
of distorting antigen recognition due to the use of certain fixatives (Tan
1932),
Cytoplasmic antigen recognition has also been seen in a variety of
conditions. Antibodies reactive with ribosomes were described in lO'^'?
(Schur, et al., 1967). The two antigen systems Ro and La likely reside,
though perhaps not exclusively, in the cytoplasm (Clarke, et al,, 19^0;
Mattioli and Reichlin, 1974).
V/hile antinuclear antibodies are associated with a variety of
rheinatic diseases, certain other conditions may also present with this
category of antibody reactivity. Nuclear autoantibodies have been
described in melanoma, nasopharyngeal carcinana, and acute and chronic

leukemia patients (Morton, et al., 196«; McBride, et al., 1Q7:?. yoshida, et
al., 1975; Lamelin, et al., 1Q7P; viein, et al., 107/^. steiner, et al.,
1975). Chronic liver disease (Ziegler, et al., 1Q75) may also be
associated with such autoantibodies including cytoplasmic microsomal
reactivity (Oavis T931) and the antimitochondrial antibodies (Davis i9Pi)
seen in primary biliary cirrhosis (Ahrens, et al., 1^50).
At approximately the same time as the first reports of nuclearreactive serun components, came the observations of DNA-reactive antibodies
(Robbins, et al., 1957; Cepellini, et al., 1957; Seligmann, 1957). use of
immunodiffusion analysis (Tan, et al., 1966) allowed for the distinction of
two differing specificities of DNA reactive antibodies. Sera were described
which reacted with both native (double stranded) and heat denatured DNA,
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while others reacted with only heat denatured DMA.

Tn

addition

to

these

specificities, a third reactivity sp)ecific only for native nN» has been
described to occur at low frequency (Arana and Seligmann, 1967; Tan and
Natali 1970; Koffler, et al., 1971; and Gilliam, et al., 1930). While
antibodies reactive with native DNA appear generally to recognize
determinants on the sugar-phosphate backbone (Stollar 1P70; Picazo and Tan
10*75; samaha and Irwin io7«^; steinman, et al., 19'^'^) single strand DNA
specific antibodies appear to recognize the nitrogen bases (Tan io32). An
intriguing distinction between these two anti DNA reactivities is the
relative ease with which antibodies to single stranded DN^ are induced by
immunization in animals as compared with a corresponding difficulty for
dsDNA (Tan 1032), although certain animal models of SLE contain such native
DNA antibodies.
Clinical correlations with anti-DNA antibodies have been numerous,
both in suggesting possible etiology of tissue injury in SLE and as a
diagnostic marker. The importance of immune complexes in generation of
glomerulonephritis and vasculitis was demonstrated both for exogenous
antigen administration in models of serin sickness (Dixon, et al., 1^59,
1061) and by direct injection of preformed immune complexes (McCluskey, et
al., 1960), Vasculitic and glomerular lesions were shown by
immunofluorescence to contain antibody deposits as well as associated C,
further implicating such immune complexes in a pathogenic role in SLE
(Vasquez and Dixon, 1957; Mellors, et al., 1Q57; paronetto and Koffler,
1965; Lachnann, et al., 1962). The sequential appearance of DfA reactive
antibodies followed by a rise in free serim DNA antigen with loss of serum
DNA antibody during a SLE flare was highly suggestive that the DNA antigen
antibody system was functionally important in SLE tissue damage (Tan, et
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al., 1966).

Immunofluorescence and elution

techniques

demonstrated

both

DNA antigen and DNA reactive antibodies in affected renal glomeruli. While
the involvement of DNA antigen antibody complexes in glomerular and
vasculitic lesions appears firmly established, correlations of disease
activity with DNA antibody titers cannot exclurie consideration of antigen
load since these two parameters must likely occur within certain

stoichiometric constraints to form pathogenic immune complexes (Tan "•oqo).
Antibody to native DNA is most frequently associated with SLE, although
titers (usually lowl have been observed in other of the rheumatologic and
connective tissue diseases (Tan 1932; Davis 1931). single stranded DNA
reactive antibodies have much wider disease distribution including
rheumatoid arthritis, chronic active hepatitis, and infectious
mononucleosis (Koffler, et al., 1971).
Histone reactive antibodies (Kunkel et al., I960; Stollar 1971) have

been detected in lupus (both idiopathic and drug induced) and in rheumatoid
arthritis (Tan 1032). Lupus induced by pharmacologic agents (e.g.
procainamide, hydralazine, and isoniazid) is very frequently associated
with histone reactive antibodies (Fritzler and Tan, 1073) while such
reactivity is less frequently observed in idiopathic SLE. Ttie possibility
that certain {xirified rheumatoid factors may contain anti DNA-histone
reactivity suggests intriguing relationships between these otherwise
distinct classes of autoantibodies (Alspaugh, et al., 1973; Agnello, et
al., 1973; Hannestad and Stollar 1973).
Other groups of autoantibody-antigen systems include the Ro and La
antigens which are RNA containing nucleoprotein complexes. These antibody
reactivities are generally thought to be confined to SLE and Sjogren's
syndrome (Alspaugh, et al., 1976; Kassan, et al., 1977; Akizuki, et al..
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]077; provost 1079).

Antibodies

to

proliferating

cell

nuclear

antigen

(PCNA) described by Myachi, et al. (107q) are seen in a small proportion of
SLE patients. Other autoantibodies include centromere/kinetichore (Moroi,

et al,, 1030; Brenner, et al., 1931), a 70 kd antigen reactive with certain
scleroderma sera (Douvas, et al., 1979b), and a nuclear antigen recognized
by antibodies in a significant proportion of rheunatoid arthritis sera
(Alspaugh, et al,, 107^; Alspaugh and Tan 1976). Several additional
systems have been described in dermato/polymyositis and overlap syndromes.

Among these are the PM-1 (Wolfe, et al., 1977), Mi-1 (Nishikai and Reichlin
1930a), Jo-1 (Nishikai and Reichlin lOPOb), and vu (Mimori, et al., I^PI)
antigen systems.
Many of the nuclear antigens recognized by these numerous categories
of autoantibodies are easily removed from nuclei by isotonic extraction.
The Sm/RNP antigen antibody system was first described in i066 (Tan and

Kunkel 19'^'^) as a saline extractable nuclear antigen. While other antigen
are also saline extractable, the Sm and RNp systems contain several
distinguishing features which have facilitated identification of these
reactivities. Analysis of precipitin patterns has distinguished these
reactivities (Northway and Tan 1.072). Use of a hemagglutination assay

aided in differentiating between Sm and RNP, and is used as a clinical test
for these antigens (Tan and Peebles 1976). Sm and RNP reactive antibodies
generally reveal a speckled pattern of nuclear staining by indirect
immunofluorescence.
Initial investigations regarding the molecular composition of the
Sm/RNP antigens and reactivities revealed RNP sensitivity to RNase
digestion while Sm recognition displayed no such sensitivity (Northway and
Tan 19*72). The anti-Sm antibodies are highly specific for SLE while anti-
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RNP antibodies show wider distribution and

have

helped

in

defining

the

mixed connective tissue disease syndrome (Sharp, et al., if^7p). This
disease was described in rheumatologic patients with features of SLE,
scleroderma, and dermato/polymyositis whose sera contained antibodies
directed against an RNase sensitive nuclear component. Ttie frequent
occurance of Raynaud's phenomenon and the absence of renal disease also
characterized this disorder. At nearly the same time, Mattioli and
Reichlin (19*^1) reported the occurance of an RNase sensitive extractable
nuclear antigen called Mo. Reactivity with this antigen was seen in 30 to
50% of SLE patients, and it was subsequently shown to be identical to RNP
(Tan, et al,, 1977), So while Sm reactivity shov/s high specificity for SLE
(although seen in only 30-40% of patients), RNP reactivity can be seen in
SLE or MCTD, as well as discoid lupus, scleroderma, rheumatoid arthritis,
and Sjogren's syndrome (Tan 1032).
Notman, et al., (1975) tested numerous patients for RNP reactivity and
observed uniformly high titers in MCTD patients and lower frequency of high
titer in SLE as well as other syndromes. There has been some uncertainty
over the classification of MCTD as a distinct disease syndrome.
Distinguishing MCTD from dermato/polymyositis and scleroderma may be of
particular importance because of the good response to steroid therapy of
the former, but not the latter disease (Tan 1037). MCTD appears to be
distinguishable from other related syndromes by the presence of high titers
exclusively to RNP- other conditions more likely reveal additional antibody
reactivities (Tan and Peebles 197?;), Thus, Sm antigen reactivity is seen
in 30-40% of SLE patients and represents a specific disease marker; RNP
reactivity, while seen in a variety of disorders, may contribute
significantly to the diagnosis of MCTD (in the absence of other antibody
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reactivities) and is associated with favorable prognosis in those cases.
Since the discovery of Sm antigen reactivity in i96^ (Tan and Kunkel,
196^=^) and RNP in the early 1070's (Mattioli and Reichlin "«Q7i; sharp, et
al., 1072; Northway and Tan 1077) numerous studies have been carried out,
aimed at defining the biochemical composition of these nuclear antigens.
Northway and Tan (1977) used DEAE chromatography, gel filtration, and
sucrose density centrifugation to show that while some Sm reactivity could
be isolated separate from RNP, the rest always copurified with RNP-reactive
antigen. This finding was confirmed by Mattioli and Reichlin (io"77).
Numerous reports have been made regarding the putative protein constituents
of snRNPs. While little agreement appeared at first, a consensus is
beginning to emerge from reports of recent years, Douvas, et al, fio70a)
used anti RNP affinity columns to describe two proteins of T* and "^o kd.
Takano et al. (1031) described RNP antigens of 30 kd, 13 kd, and '^^ kd

while Sm antigen appeared to be several peptides in the 1'^ kd weight range.
Agelli, et al.. (1930) described a =^5 kd protein thought to be Sm. Waelti
and Hess (lOPO) identified putative Sm antigens of 110 and 7D ^a. Barque,
et al. (1931) described 4 Sm and RNP polypeptides in the 10-70 kd weight
range. White and Hoch (1931) described several Sm and RNP peptides using
immunoblots. Lerner and Steitz (107Q) reported 7 peptides in the weight
35
range

of

12-35 kd, immunoprecipitable from

~S-methionine labeled Ehrlich

ascites mouse cells, itiis pattern of peptides ranging from 32,000 d to
9,000 d and named A through G, has been recognized by a number of
independant investigators in recent years (Conner, et al., 1032; Matter, et
al., 1932; Kinlaw, et al., 1933; Wieben, et al., 1033).
Lerner and Steitz (1979) demonstrated that immunoprecipitates from
nuclear extracts using Sm and RNP sera contained U series small nuclear RNA
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species. While Sm sera precipitated Ui, U2, u^,

U5,

and

U^,

RNP

sera

precipitated Ul RNA only. These observations both assigned a biochemical
niche to these previously described RNA's and provided the suggestion that

Sm and RNP antibodies may be of great use in further analysis of structural
and functional properties of the U RNA containing complexes.
The U series small nuclear RNAs comprise 0.1-1% of total cellular RNA.
They were named (Hodnett and Busch l9^o) for their uridylic acid-rich
nucleotide composition. Small nuclear RNAs have been identified in normal
and malignant cells, vertebrates, invertebrates, dinoflagellates, and
plants (Reddy and Busch, 1933). Numerous small RNA species have been
identified in addition to these U RNAs. The 7s species (Bishop, et al.,
1970) is one which has been demonstrated (Walter and Blobel 19^2) to
participate in a known biological activity. In association with several
peptides, this RNA forms the signal recognition particle shown to be

critical in polysome-endoplasmic reticulum interactions during translation
of membrane and secretory proteins (Walter and Blobel I03ia,b; Walter, et
al., 1931). Another small RNA with known functional importance is the
species contained in the e. coli RNase p complex, a particle involved in

tRNA maturation (Kole and Altman 19*79) . Ttiese two small RNAs (7s and RNa
P) differ from U series RNA in lacking 5' caps. The U RNAs all contain
methylated caps at their 5' ends and are RNA polymerase II transcripts, as

demonstrated by alpha-amanitin sensitive transcription. Trimethylguanosine
(Saponara and Enger 1969) was identified in Ul, U2, and [P RNAs (Reddy, et

al., 1972)- present in a =^'-5' triphosphate linkage (Rottman, et al., lo7/
Ro-Choi, et al., 1075; Reddy, et al., 1976). Fbllowing the discovery of
these caps on U RNAs, similar such caps were discovered in viral and
eukaryotic mRNAs (Rottman, et al., 1974; shatkin, et al., 1076) containing
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7-methylguanosine.
Ul RNA was identified as a nuclear species by cell fractionation
(Weinberg and penman 1963; Hodnett and Busch IO^P). Sequence analysis has
led to postulated models which predict a secobdary structure involving

formation of ^ hydrogen bonded stems (see Figure 1) (^-'rol, et al., lOPi

Enzymatic digestion followed by immunoprecipitation (Epstein, et al., lop
suggests 2 regions of susceptibility: the 7 most 5' nucleotides, and the
region near nucleotide 107. These regions (particularly the 5' end which
undergoes less 2^ folding, see Figure 1) are good candidates for
participation in the formation of transient base pairs with splice
junctions. After Ul RNA the next most abundant small nuclear RNA species
is U2. This species contains 2'-0-methylated nucleotides and an unusual

number of pseudouridine residues at its 5' end. A U7-like species has bee
found in wheat and differs only slightly from rat U7. u^ RNA is a
nucleolar sp>ecies, capable of hydrogen bonding to 35S and 2*^^ RNAs
(Prestayko, et al., 107i) and is not precipitated by Sm or RNP sera. It
resides as a ribonucleoprotein complex in nucleoli (Prestayko, et al.,
1971). U^ is another nucleoplasmic species containing the
trimethylguanosine cap (Krol, et al., 1931 a; Reddy, et al., IOPI). it

bears extensive homology to Ul and is highly conserved (as is the case wi
the other u RNAs)(Krol, et al., 1031). U5 RNA is the most uridine rich u
RNA (Krol, et al., 1931b). It also contains the trimethylguanosine cap

(Krol, et al., 1931a). Tn contrast to the other U RNAs, the U6 RNA specie
lacks trimethylguanosine in its cap and contains numerous methylated
nucleotides in its central sequences. Other U species are methylated on

nucleotides towards the 5' end of the molecule. Ttie suggestion that U6 m

associate with newly transcribed RNA (Reddy and Busch, 10P3) may implicat
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this species in some aspect of RNA processing.
Ttie synthesis and metabolism of U RNAs is of considerable interest in
relation to snRNPs. Larger than mature precursors of Ul and U2 have been
identified in the cytosol following H-uridine pulse labeling (Elcieri
1974; Fredericksen and Hellung-Larsen 19''5; Zieve and Penman io7^),
Salditt-Georgieff, et al., (1930) have identified snRNA precursors by

virtue of their methylated cap structures. u\^ irradiation (to which snRNT

transcription is sensitive^ has suggested transcription units for Ui and U

as large as 5 kb (Elcieri 1070). Transcription thus appears to be followed

by very rapid (<10 minutesl transport of precursor species to the cytoplas
where further methylation (processing) may occur.. Within i5 minutes,
mature forms of these U RNAs appear in the nucleus- these nuclear forms

being quite stable as would perhaps be expected if the RNAs were associate
with proteins, TVo additional sets of experiments have been carried out
which bear on cellular location of these RNAs, Microinjection of the RNAs

in the cytoplasm is followed by transport into the nucleus, where they are
associated with snRNP proteins (DeRobertis, et al., 1937), Nuclear
transplantation in ameba (Goldstein, et al., 19'77) has suggested that U
RNAs shuttle between the nucleus and cytoplasm. A considerable proportion
of snRNPs have been suggested to associate with the nuclear matrix
(Vogelstein and Uxint 1932). Deng, et al. (1931) have shown an intriguing
change in location of sm antigen related to the cell cycle, Sm reactivity

can be seen in the nucleus during Gi and S. However, Sm antigen appears to

be located outside the nucleus during G2 and away from the chromatin durin
mitosis. Several unique features of the genes encoding U RNAs have been

described. Ttie genes appear to be dispersed throughout the genome althoug
with similar immediate surroundings (Roop, et al, 1051; Manser and
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Gesteland 1931; Denison, et al., IOPI; Manser and Gesteland

19^7).

itjese

genes lack intervening sequences and polyadenylation signals (AATAAA near
the 3' end of the RNA) (Reddy and Busch lop-?; Roop, et al., lOPi; Manser
and Gesteland 1032). As many as 10 fold more pseudogenes exist for Ui-7
RNAs than true genes (Denison, et al., lOPi).
Based on various structural features of the Ui R^^a, the suggestions
have been made (Lerner, et al., 1930; Rogers and Wall 1<^30) that this
species may participate in RNArRNA splicing. U RNAs have been seen to
associate with hnRNPs (Sekeris and Niessing lO""^) and to be capable of
hydrogen bonding to hnRNA (Northemann, et al., 1077; Northemann, et al.,
1079). Crosslinking studies have also identified ui and U7 RNAs in
association with hnR^!A (Calvet and Pederson 2031; Calvet, et al., 1OP2). A
consensus sequence found near the 5' end of Ul RNA bears homology with
known splice junctions. This 5' end sequence is identical in all known m
species. Ul RNA containing snRNPs appear to be capable of binding to 5'
splice junctions in vitro (Mount, et al., 1033). Several experiments have
demonstrated selective blocking of splicing events when anti-Ul snRNp

antibodies were added to isolated nuclear (Yang, et al., lOPi) or in vitro
(Padgett, et al., 19«*3) transcription/splicing systems. Ttje splicing
activity of another in vitro transcription/splicing system has been shown
to reside in a fraction containing snRNPs (Hernandez and Keller 1033).
Perhaps argueing against this role for Ul RNA in splicing is the

observation of Weissman, et al. (19^2). Ttie splicing efficiency of globin
precursor RNAs which contained changes in the Ul homologous consensus
sequence was high, despite lost complementarity to Ul. Other roles for

which U RNAs have been postulated include transport (Reddy and Busch, 1937
Hellung-Larsen and Fredericksen i077), control of transcription (Britten

_!-?_

and Davidson '}^'=>9; Prestayko, et al., 107i; Hellung-Larsen and Fredericksen
1977; Light and Molin i937), and chromatin structure (Pederson and Bhorjee
19*79).
Considerably more is known at the structural and biochemical level
about the U RNA species than the proteins with which they associate in
snRNPs. Since these proteins undoubtedly underly a significant role in the
structure and perhaps function of snRNPS, further study of these species
may be useful in improving the understanding of snRNP particles. Ttie four
following chapters describe experiments carried out with that purpose,
making use of the naturally ocurring antibodies reactive with snRNps, those
of the Sm and RNP specificities seen in SLE and allied autoimmune diseases.

Figure 1

proposed secondary structure for rat U-i RNA
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Chapter 2

Protein Constituents of snRNPs

ABSTRACT

The protein constituents of small nuclear ribonucleoproteins (snR^Tps>
35
have

been

analyzed

by

S-methionme

internal

labeling

followed

by

immunoprecipitation with SLE sera. The eight peptides termed A-G were
identified and further studied by in vitro translation analysis. Each

protein was synthesized by the wheat germ cell free extract in the presenc
of appropriate RNA. Furthermore, protease digestion studies and RNA
fractionation coupled to in vitro translation have revealed that these
eight snRNP proteins are encoded by separate mRNAs and are not related by
post-translational cleavage.
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Chapter 2
RESULTS

Endogenous Labeled SnRNP Proteins
Considerable controversy has historicaly surrounded questions of the
identity of protein constituents in small nuclear ribonucleoproteins.
Immunoprecipitation studies were carried out to analyze this question,
utilizing human autoimmune sera shown to be reactive with these particles.
Metabolic labeling was carried out on the human myeloid cell line K552
35 . . .
using
S-methionme

and incubating for 15 hours m RPMT 1^40 mediim made

deficient in methionine. Immunoprecipitation was carried out using serum
from a patient with SLE, displaying anti Sm serology as determined by
75
passive

hemagglutination.

S-methionine

labeled

cells

were

lysed

hypotonically and nuclei extracted using 0.2 M NaCl. Post nuclear
supernatent was immunoprecipitated by anti sm antibodies followed by
Protein A Sepharose 4B, washing, elution, and SDS-polyacrylamide gel
electrophoretic analysis.
Figure 2 shows the pattern of precipitated ^^S-labeled peptides when
anti Sm (lane 1) or normal human serum (lane 2) are used. The eight
peptides labeled A-G migrate with mobility corresponding approximately to:
A- 32,000 d
B- 25,000 d
B'- 25,000 d
C- 19,000 d
D- 15,000 d
E- 12,000 d
F- 11,000 d
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G- 8,000 d.

Since the snRNP proteins reside in particles in vivo, it was felt to be
likely

that any nonantigenic snRNP peptides should be visualized following

immunoprecipitation
further

for

the

by

virtue

anti

RNP

of

coprecipitation

phenomena

serology in Chapter 3).

(discussed

The possibility that

other snRNP peptides may show sensitivity, particularly to divalent
concentrations

has

been

tested

cation

under conditions of 5 mM MgCl^ and 25 mM

EDTA revealing no apparent sensitivity of snRNP components to these

agents

(data not shown).
In vitro Translation of SnRNP Proteins
Further analysis of
translation.

RNA

was

snRNP

peptides

was

carried

out

by

in vitro

extracted from ^5^*^ cells and the p»ly A+ fraction

was translated using wheat germ cell-free extract.
translation products is shown in Figure 3,

Immunoprecipitation

of

All eight peptides were clearly

seen from precipitates of poly A4- RNA translation products.

Ttie poly

fraction

(defined

dT cellulose)

appeared

to

possibility

only

contain
certainly

by

repeated

mRNAs
exists

for

passage

most

that

of

over

the

residual

oligo

peptides,

A+

although

A-

the

RNA was present in this

fraction. Relative decreases in A, B, and B' are seen as well, in products
of

total

RNA

translation.

V^ftiile it is difficult to accurately compare

quantitative aspects of these different fractions, the presence
snRNP

peptides in the poly A+ translation is firmly evident.

no gross changes in mobility are seen for any of the peptides
in vivo

labeled

of

Furthermore,
relative

to

snRNPs, an observation which has been made by runnirig in

vivo and in vitro generated snRNPs in adjacent lanes of the same gel
not shown).

all 3

(data

-IP-

proteolytic Cleavage Patterns
Preliminary experiments were carried out to study relatedness of the
various snRNP peptides. protease cleavage was carried out with
chymotrypsin and protease V^ to search for possible precursor-product
relationships among the proteins. A typical experiment with such analysis
is illustrated in Figure 4. Tn vivo S-methionine labeled,
immunoprecipitated snRNP peptides A, B, B', and D were cut out of an SDS
polyacrylamide gel (as in Figures 2 and 3) and subjected to proteolysis
with chymotrypsin according to the method of Cleveland, (1977^Enzyme
concentrations of 10, 1, and 0.1 ug per lane were used, as indicated. Ttie

untreated peptides are seen to migrate essentially the same as in Figures 1
and 2, with some differences due to the 20% polyacrylamide concentration
used in the proteolysis gel (vs. 15% in other experiments) . Comparison of
the cleavage patterns for these four peptides reveals no striking
similarities. While occasional proteolytic fragments comigrate for
different peptides, the vast majority of lytic products form migration
patterns which appear to be unique for each protein.
Fractionation of RNA Encoding snRNP Proteins
To further study the possibility that precursor-product relationships
exist among the 9n-precipitated snRNP proteins, size fractionation of poly
A+ RNA was carried out prior to in vitro translation. If any two of the
snRNP proteins are encoded by the same mRNA, but differ by posttranslational cleavage or processing, then their mRNAs should not be
separable by size fractionation. K562 poly A+ RNA was fractionated on a
10-30% sucrose gradient, each fraction was translated, and the products
were immunoprecipitated with sm serum. Figure 5 shows such a fractionation
experiment. Tn 5a, 3 ul of total translation products were analyzed

_-^a-

(without

iimunoprecipitation) , Clear evidence appears for different sized

proteins derived from the RNA gradient fractions. Figure 5b shows
translation products immunoprecipitated using an sm serum. The eight Smprecipitable proteins are seen to be resolved into seven fractions. Ttie
mRNAs for proteins A-G appear to migrate separately in the sucrose

gradient. It is noteworthy that the peak fractions of mRNA for proteins B

and B' are reversed relative to the sizes of the two proteins. Ttiese dat

suggest that the eight snRNP proteins are translated from separate mRNAs.

Furthermore, it was observed that the sm serun was able to precipitate th
eight labeled snRNP proteins in the absence of one another.

DISCUSSION

Immunoprecipitation coupled to cell free translation studies have been
carried out to analyze the biochemical identity of snRNP proteins. Tine
results have demonstrated that all ^ snRNp proteins defined by
35
precipitation from

S-methionine labeled cells, can be translated m vitro

and recognized by SLE sera. SDS-polyacrylamide gel electrophoretic
migration revealed no apparent differences in mobility of the snRNP
proteins generated in vitro and in vivo (Fig. 3) suggesting that major
post-translational processing events either to not occur or have occured
completion in the translation system. Itie observation that the RNA's

encoding the 3 proteins were separable discounts the possibility that the
proteins are related as precursor-product. Ttie data suggest that eight
separate mPNA's encode snRNP proteins A-G. Furthermore, the relative RNA
sizes correspond to the protein molecular weights (as judged by sucrose
gradient migration). The only exception is the mRNA for protein B* which

-20-

migrates as a larger RNA than that

encoding

B.

Tn

light

of

the

very

similar sizes of proteins B and B* as well as the appearance of only one

"B" band following immunoprecipitation of rodent snRNP's fLerner and Steitz
1979), it is of significance that they are translated from separate
messages and are not variants of the same primary translation product.
Chymotryptic peptides also clearly distinguish the proteins from one
another (Figure 4). Ttie reports (Conner, et al., 1937; petterson, et al.,
193/1) that a monoclonal antibody is capable of recognizing proteins B and
is of related interest. While the possibility that these proteins are
related as precursor-product appears unlikely, the sharing of antigenic
determinants suggests the possibility of some relationship among these
proteins at either the DNA or mRNA processing levels although no obvious
shared proteolytic fragments were observed for these proteins (Figure 4).

Shared determinants could suggest that a limited idiotype repertoire may be
sufficient for recognition of the many snRNP proteins by autoimmune sera.

Several groups have described an antigenic peptide of approximately 5**,00
thought to be contained in certain snRNP particles (Hinterberger, et al.,
1933; Kinlaw, et al., 1983; White and Hoch 1931). While larger peptides
appear in immunoprecipitates and immunoblots with certain sera, screening
in this laboratory of numerous MCTD and SLE sera has not revealed

correlation of any particular high molecular weight band with either 5*n or
RNP serology (Conner, et al., 1932). Antibodies against a nuclear matrix
protein of approximately the same molecular weight have been described in
many MCTD sera Habets, et al. (1983). Further studies regarding the
identity and immunogenicity of these larger peptides are currently in
progress, utilizing several recently generated monoclonal antibodies (W.
Reeves, personal communication). Experiments in this laboratory have not
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demonstrated

the presence of any additional snRNP peptides in the range of

15,000-33,OOOd (other than A-G), as reported by several other groups
(Hinterberger, et al., 1933; Kinlaw, et al., 1933). While occasional

immunoprecipitates have revealed such additional bands, comparison of total
lysate proteins has generally revealed those species to correspond to very
abundant cellular proteins. Lack of these bands in immunoprecipitates of
in vitro translation products from size fractionated poly A-»- RNA (Figure
5b) supports this notion.

Figure 2

Small Nuclear ribonucleoproteins recognized by

Sm

serum.

S-methionine

labeled K552 cells were lysed and immunoprecipitated using normal human
serum (NHS) or Sm autoimmune serum (Sm). SnRNP peptides A-G are labeled.

Figure 3

In vitro translation of shRNP proteins.

RNA from the K=^52

cell

line

was

extracted, and either translated directly (tot.) or fractionated into poly
A+ (A-*-) and poly A~ (A~) fractions prior to translation using wheat germ
cell free extract. Translation products were immuno precipitated with Sm
serum.

A + tot. A -

A
B
r
^^^

•5-

=r

Figure 4

peptide mapping of ^ snRNP peptides,

peptides A, B, B*, and D were excised

from a resolving SDS gel as gel slices, v*iich were placed into wells of a
20% SDS-polyacrylamide gel and overlaid with chymotrypsin in loading buffer
(either 0.1, 1, or 10 ug enzyme per lane as indicated). Samples receiving
no enzyme are labeled "uncut." peptides were run into the stacking gel,
allowed to digest at room temperature, and then resolved as described
(Cleveland, et al., 19*^''). "I^e cleavage patterns do not resemble patterns
predicted for post-translationally modified forms of the same peptide.

^ r " K ./?v ./B'\. /K

/H\

Figure 5

Sucrose gradient fractionation of mRNAs encoding shRNP proteins. K562 poly
A-i- RNA was fractionated on a 10-30% sucrose gradient and precipitated with
ethanol, and each fraction was translated in a cell-free system.
shows

3 ul

aliquots

of

total

Figure 5a

translation products from each fraction.

Figure 5b shofws sm immunoprecipitates

of

translation

fractions. Lane 1 represents the top of the gradient.

products

from

the

B
total products
3
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Chapter 3

Specificities of the snRNP reactive human autoantibodies, anti-Sm and anti-RN

ABSTRACT

Antibodies directed against small nuclear ribonucleoprotein (snRNP^
particles are found in the sm and RNP autoimmune sera from numerous
patients with systemic lupus erythematosus (SLE) and mixed connective
tissue disease (MCTD). While these autoimmune sera contain snR^TP reactive
antibodies, distinctions in antigen binding specificity have been difficult
to define because of the particulate nature of the snRNP antigen. To
overcome this problem, while obtaining the antigen in a native state,
cell-free translation of poly A+ RNA was carried out. In addition, cells
35
were

pulse

labeled

with

S-methionine

for

3

minutes

to

generate

radioactive snRNP proteins in forms reflecting incomplete de novo particle
assembly. Immunoprecipitation of snRNP antigen prepared in these manners
revealed clearly distinct patterns of Sm and RNP immunorecognition. While
sm sera precipitated all 3 labeled snRNP proteins, RNP antibodies
precipitated only 2 of the eight. One of the proteins (the A protein) of
32,OOOd was seen to lose antigenicity upon RNase treatment either when
extracted from cells or when generated in vitro. RNase treatment of
immunoprecipitated snRNP*s released the A protein in an electrophoretically
pure form. Analysis of in vitro translated snRNP's has revealed the
presence of both unassembled and assembled particles as determined by
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sucrose

density gradient

sedimentation.

Post-translational assembly of

snRNP's involving both RNA-protein binding (as revealed by A protein
antigenicity) and associations of other snRNP proteins occured in the in
vitro system employed here. In addition to antibodies to the other 5 snRNP
peptides, all Sm sera tested have been found to contain the RNP-like
reactivity with snRNp proteins A and C. TVro patients were observed to
switch with time from Shi to RNP-like snRNP recognition. Selective
reactivity with A and C proteins is of particular interest because these
proteins are unique in the metabolism of snRNPs.

-'?fi-

Chapter 3
RESULTS

The two serotypes which display reactivity with snRNPs are Sm and RNP.
Ttiey have been distinguished by virtue of an apparent RNase sensitivity of
the antigen recognized by RNP sera (Mattioli and Reichlin 1971; Sharp, et
al., 1972; Northway and Tan 1972).

Analysis of the protein constituents of

snRNPs has resulted in differing, although likely
the

precise

components

of these particles.

(see Chapter 2) together with the
Kinlaw,

reports

compatible,

reports

on

In vitro translation studies

(Hinterberger,

et

al., 1Q33;

et al., 1933) of nonimmunological snRNP particle purification have

allowed at least 3 separately translated proteins to be identified as snRNP
constituents.
Identification of which species are specifically recognized by Sm
RNP

serum

antibodies

noncovalent

has

interactions

Immunoprecipitation

of

been

plagued

which

hold

endogenously

by

and

difficulties related to the

snRNP

particles

together.

labeled snRNPs has therefore been of

limited value in delineating distinctions between peptide recognition by Sm
and

RNP

sera. Detergent treatment and immunoblot (Western) analyses have

revealed several differences in the serologies. However, identification of
all

antigenic

peptides

requires

native

undenatured proteins since most

snRNP peptides are not recognized by SLE antibodies following

exposure

to

denaturing detergents.
Sm and RNP Antigen Recognition of snRNPs subjected to extended labeling
Extended in vivo labeling of snRNPs was carried out by
K552

cells

for

15 hours

in

the presence of

incubation

S-roethionine.

immunoprecipitation results in identification of the

eight

of

Lysis and

proteins

A-G,
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uniquely

precipitated

by

both Sm and RNP sera, but not with normal human

serum (Figure 5 ) . Although various higher molecular weight bands have been
seen

as well, including several uniquely recognized by certain sera, these

have not been correlated with either Sm or RNP serology

(Conner,

et

al.,

1982).
Sm and RNP recognition of Jri vitro generated snRNP proteins
Previous work has indicated that bands A-G exist in complex

particles

which could be dissociated by mild detergent treatment during extraction of
antigen from labeled cells (Conner, et al., 19^2).
distinguishable
particles)

are

denaturation

subsets

of

recognized

destroys

these

by

Sm

reactivity

and

RNP

with

most

alternative to particle disruption by
snRNP's

might

facilitate

reactivities with native snRNP
identified

the

eight

Furthermore, unique and

proteins
sera,
of

components.

of

detergent

proteins.

incompletely

Sm

Such

dissociated

although

the

detergents,

analysis

(from

and

RNP

As

an

assembled
serological

reactivities

might

be

by immunoprecipitation of products from in vitro translation of

snRNP peptides. Wheat germ extract (Erickson and Blobel 1^33) was utilized
for

in

vitro

translation

of

K^f^'> poly

immunoprecipitation using an and R N P sera.
of

such

A+

RNA,

followed

Figure 7 shows typical

serum

results

experiments. As with in vivo generated antigen (lane "»), Sn serum

precipitates all eight proteins from translation products (lane
RNP

by

(lane 3) precipitates only proteins A arv3 C.

7), while

Five different Sm

and RNP sera gave similar results. Ttius markedly different patterns of
and

Sm

RNP antigen recognition have been detected using cell-free translation

products. Such unique patterns are not seen when antigen is prepared

from

cells which have been radioactively labeled for an extended period of time
(Fig 5 ) . Precipitation of all snRNP proteins
proteins

labeled

in vivo

probably

by

results

both
from

sera

using

associated

snRNP

particle

--co-

precipitation

by

RNP

serum,

although

only

two

proteins

are

being

immunologically recognized. Analysis of unassociated proteins allows for
more accurate determination of individual protein reactivities.
In vitro particle Assembly
From the data presented it was impossible to be certain whether the Sn
sera used in these studies are recognizing each of the snRNP proteins
independantly or precipitating all eight by virtue of narrow specificity
and coprecipitation of proteins assembled into particles or particle
precursors. Even in the RNA fractionation experiment (Figure 5) the
possibility remained that each separate protein was associated with
unlabeled proteins or snRNP particles present in the wheat germ extract
system. To address this question, products of translation in vitro were

subjected to sucrose gradient fractionation followed by immunoprecipitation
with Sm serum. As shown in Figure 3, bands B-G are present in the first
seven fractions, which represent sedimentation coefficients less than 75.
Band C was seen in the top two fractions upon longer exposure of the gel
(data not shown). Mature snRNPs have been reported to sediment at
approximately 5-1 IS (Mattioli and Reichlin 1971; Northway and Tan i972;
Howard 1973; Lerner and Steitz 1979). itie presence of these snRNP proteins
in fractions of low S value suggests that the proteins are present as
separate monomeric species, unassociated into complexes. On the basis of
their immunoprecipitation in this form, it is apparent that 9n serum does
contain antibodies capable of recognizing proteins B-G individually. The
greater mobility of D relative to the other proteins is of some interest.
It suggests either that D has associated with other species (e.g. protein
or RNA) or that it has an unusual three-dimensional configuration
accounting for its larger S value. In this regard it may be of related
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interest

that

D

protein

appears

to

split

into

a doublet

upon

immunoprecipitation with certain sera (see below). Further examination of
Figure 3 also reveals the presence of snRNP proteins in fractions of

approximately 7 and 11S. Ttie presence of snRNP peptides in these fractions

suggests that limited particle assembly is occuring during or subsequent to
translation in vitro. Tlie finding that snRNP proteins are present in
approximately 7S and US fractions is similar to previous observations

(Mattioli and Reichlin 1971; Northway and Tan 1972; Howard 19*73; Lerner an
Steitz 1979) that there are two size classes of snRNP particles. Although

particle assembly can occur in the cell-free translation system, most snRNP
proteins exist in unassembled form (Figure 3), a fact that allowed the
distinction between Sm and RNP recognition (Figure 7), Nevertheless, the
ability to generate assembled snRNPs in vitro may provide a means for
analysis of the protein-protein and protein-RNA interactions that
undoubtedly underlie the biological functions of these nuclear complexes.
Recognition of pulse labeled shRNPs
A second source of labeled snRNP proteins v^ich may represent
incompletely assembled particles may be generated by brief pulse labeling
of K552 cells with S-methionine, rather than labeling for an extended
period of time. A titration experiment was performed in v^ich K552 cells
were starved of methionine for various times prior to 3 minute pulse
35
labeling

with

S-methionine, extracting, and anti-Sm immunoprecipitation.

As seen in Figure 9, only with some starvation were all eight peptides well
labeled. itie selective absence of A protein is somewhat striking in the
total absence of methionine starvation ("0 starvation") and may relate to
the kinetics of A protein metabolism in K552 cells. All pulse-labeling

experiments performed subsequently, made use of cells previously starved of
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methionine

for

0.2

to

2

hours.

The

results

of anti-Sm and anti-RNP

35
immunoprecipitation following an eight minute pulse of

S-methionine

are

shown in Figure 10. The three Shi sera shown (lanes 2, 3, and 7)
precipitated all eight snRNP proteins, v^ile the three RNP sera (lanes 4,
5, and 5) precipitated proteins A and C only. Normal human serum (lane 1)
precipitated none of these proteins. Ttius, although all eight particle
35
proteins

incorporate

S-methionine

during

an

eight

minute

pulse (as

illustrated by their precipitation with the Sm sera) , only a subset of
these proteins, bands A and C, are precipitable by RNP sera. Pulses as
short as 2 minutes gave identical results (data not shown). Studies of
over 20 Sm and RNP sera, including standards from other institutions
demonstrated the same distinct Sm and RNP patterns of reactivity in all
cases. Analysis of in vivo and in vitro synthesized snRNP proteins thus
demonstrate the same distinguishable patterns of Sm and RNP antigen
recognition.
D Band Split
In the process of analyzing snRNP recognition by numerous anti-Sm and
anti-RNP sera, a reproducible split in the appearance of the D peptide was
seen for certain sera, but not others. No correlation was seen with sm or
RNP serology. Anti-RNP patients which displayed this splitting pattern
lacked detectable antibodies to D as demonstrated by in vitro translation
and pulse labeling of snRNP proteins. Figure 11 shows an example of such a
split D pattern generated by immunoprecipitation of 15 hour labeled snRNPs
with a certain RNP serum. Mi, (lane 2). An Shi serim, Tu, which displayed
only a single protein is also seen (lane 1). While the possibility exists
that one of these bands represents a non-snRNP species such as a histone
(against which antibodies are sometimes found in SLE (Kunkel, et al. IPf^o,
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Stollar, 1971), the comigration of both D bands at 10S in sucrose gradients
(see Figure 17 , chapter 4) suggests that they are true snRNP components.
Since antibody specificity is not likely to account for these varying
patterns- because the RNP serum has no apparent antibodies to these
peptides (Figures 7 and 10), the possibility exists that this splitting
pattern represents a serum-specific modification of the antigen which
occurs during immunoprecipitation.
To test this possibility, the following experiment was performed.

Fifteen hour labeled snRNPs were immunoprecipitated with two sera, one (Tul
which gives a singlet, and the other (Mi) which gives a doublet D.
Following adsorption of the immune complexes onto protein A Sepharose, the
beads were washed extensively with detergent free buffer. Each set of
beads was then incubated with cold (unlabeled) K552 cell lysate plus the
other serum for 1 hour at 20^C. Samples were washed, eluted and analyzed
electrophoretically. As can be seen in Figure 12a, mixing revealed that
treatment of Tu immunoprecipitate with Mi serum plus lysate converted the
single D into a doi±>let. Incubation of Tu serum plus lysate had no
apparent effect on Mi immunoprecipitate \^ich still displayed a doublet.
To test v^ether the activity giving rise to this splitting of D
resides in the lysate or is entirely in serum, the above experiment was
repeated using only serum in the post-immunoprecipitation mixing steps.
Figure I2b shows that the splitting effect was still seen when only Mi
serum diluted as before (in lysis buffer) was added to the Tu
immunoprecipitate. When the second step was carried out with Mi serum
pretreated with 1 ug/ml each of antipain, leupeptin, pepstatin (kindly
provided by Dr. Reid Gilmore) , 5 nW iodoacetamide, and 0.5 mM
phenylmethysulfonylfluoride, and mixing carried out at 4° C, splitting was
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still

seen

(data

not

shown)

despite

the

presence

of

these protease

inhibitors. While proteolysis cannot be firmly ruled out by these studies,
the

possibility

remains

that

the

faster migrating form of D protein is

modified in a serim specific fashion, and this modification (or removal
a modifying

group)

may

shed

some

of

light on the peptide's chemistry and

function.
A final possibly related point is the somewhat anomalous migration
unassembled

of

(low S value) D protein, as seen in Figure 3 in products of in

vitro translation of snRNPs.

peptides of apparent larger molecular

weight

migrated slower in the sucrose gradient than the faster SDS-gel migrating D
protein. The serum used in the experiment of Figure 3 recognizes a
D

band.

Ttie possibility

therefore

single

exists that the anomalous D peptide

mobility in sucrose gradients may relate in some manner to the presence

of

a modification which is chemically altered specifically by an unidentified
serum component in certain irx3ividuals.
RNase treatment of snRNPs
To

examine

the

immunorecognition

by

protein
SLE

and

sera,

in

RNA

components

responsible

for

vivo labeled and in vitro translated

snRNP's were treated with RNase prior to immunoprecipitation.

Lanes 1 and

3 in Figure 13a demonstrate typical results of immunoprecipitation using 15
hour

in vivo

labeled

antigen, precipitated

with

RNP

and

Sm

sera

respectively.

Bands A through G are all present in precipitates using both

sera.

treatment

RNase

of

extracted

cellular

antigen

prior

to

immunoprecipitation with RNP and Sm resulted in loss of A band (lanes 2 and
4).

Examples of immunoprecipitations of

vitro

snRNP

antigen

derived

from

in

translation are shown for Sm and RNP sera in the absence (Figure 13b

lanes 1 and 3) or presence (lanes 2 and 4) of RNase treatment.

In contrast

-?t;-

to

in vivo antigen analysis, precipitation of in vitro translated products

gives unique patterns for Sm and RNP sera. In all cases, however,
precipitation of the A protein is strikingly affected by RNase treatment.
A higher molecular weight protein not known to be associated with snRNP's
precipitated preferentially with RNp serum following RNase treatment
(Figure 13b lane 4).
In an attempt to recover nonantigenic, RNase treated A protein, in

vivo labeled cell extracts were immunoprecipitated onto protein A Sepharose
beads, followed by extensive washing of the beads and subsequent RNase
treatment. Figure 13c shows RNase treated material which remained bound to
the sepharose when precipitated with RNP or Sm (lanes 2 and ^). Loss of A
protein again occured for kxjth sera. When the supernatents of the RNase

treatments were run in adjacent lanes (lanes 1 and 3), band A is seen to be
essentially the only labeled protein present. In separate experiments it
was observed that this band migrated in the exact position of the A
protein.
RNase treatment of antigen has thus been shown to abrogate
immunoprecipitation of the A protein. While RNP serology has been
distinguished from sm by virtue of an RNase sensitive hemagglutination
assay (Tan and Peebles 1975), it is significant that recognition of A
protein by Sm serum is equally destroyed by RNase. Similar results have
been obtained by using an ELISA for snRNPs (W. Reeves, personal
communication). Thus, although RNP antibodies recognize only two of the
eight 5^m-preci pi table proteins,
Sm antibodies display an equal restriction in recognizing the A protein
only in the context of an associated RNA. Tliese results are in agreement
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with the report (W ieben, et al., 1933) that ui RNA increases

antigenicity

of in vitro translated A protein. It is uncertain, however, whether it is
specifically Ui RNA that is responsible for the antigenicity of A protein
seen in the RNA fractionation experiment (Fig. 5b). Any Ul RNA present in

fractions 5 and 7 would exist despite oligo dT affinity chromatography and
sucrose gradient fractionation, which was seen to have resolved the RNA's
encoding snRNP proteins. While the possibility that trace Ul RNA is
present in these fractions cannot be ruled out, alternative explanations
exist. An RNA sp)ecies similar to Ul may be present in wheat germ extract
and be responsible for antigenicity of A protein. If so, such a species
may be revealing about comparative RNA binding specificity of A protein.
•Hie possibility also exists that an entirely different RNA species is
binding to A in these fractions. Ttie ability to generate
electrophoretically pure native A protein (Fig 13) should facilitate
further studies of its biochemical properties.

Shift from Sm towards RNP recognition in two patients in the process of
screening numerous patient sera for snRNP reactivity, using pulse labeled
cell extract to distinguish sm and RNP, an unusual observation was made.

TVo sera from the same patient which differed by several years appeared to
generate different patterns of antigen recognition. Further analysis was

carried out by immunoprecipitation analysis (of pulse labeled snRNPs) usin
sera from throughout the patient's disease course at the Rockefeller
University Hospital. Results of such analysis are seen in Figure 14.

While this patient produced a typical Sm pattern of precipitation in serum
from 19'7P, a shift in reactivity was first detected to have occurred
between 1979 and 1981. By June of 1932 the immunoprecipitation pattern is
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almost a typical RNP pattern. Some clear evidence exists for B and B' in

the immunoprecipitates indicating residual Shi reactivity, however the shif
towards RNP-like recognition is quite striking. A similar shift was
subsequently detected in a second patient (Figure 15). In this situation
first evidence for loss of sm-specific reactivity began between August and

October of 1930. Vfriile small quantities of Shi-specific bands appeared fo
about one and a half years (10/'30-3/'32), further loss of such reactivity
continued in 1982. While the possibility is currently being investigated
that these observed shifts may correlate with disease-related activities,
these examples provide an illustration of the utility of such sensitive
analytical methods in the analysis of disease conditions.

DISCUSSION

The previous inability to distinguish the fine nature of antigen
recognition of sm sera from RNP sera is in large part due to the fact that
snRNP antigens are complex particles. Antibody recognition of any
component in the particle results in immunoprecipitation of the entire
particle, itius when the antigen is radioactively labeled by prolonged
35
incubation

with

S-methionine, little if any difference has been seen in

the patterns obtained with sm and RNP sera (Figure 5). Previous attempts
to disrupt the particles using 0.5% SDS treatment have revealed
differential recognition of several snRNP peptides by Shi and RNP sera
(Conner, et al., 1932). Likewise using SDS gels and immunoblots, several
of the snRNP peptides have been observed to be uniquely recognized by Sm
and/or RNP sera and monoclonal antibodies (White and Hoch 1Q81; Conner, et
al., 1982; Petterson, et al., 1934). However many of the peptides were not
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recognized

and the

possibility

remained

that

all

snRNp

peptides are

antigenic but SDS treatment seriously alters antigenicity.
For these reasons, the present study was initiated to analyze in vivo
synthesized, native snRNP peptides. To circumvent the need for particle
disruption or detergent treatment, the strategies involved in vitro
35
translation and brief pulse labeling with

S-methionine.

By these methods

of analysis a clear distinction is seen between Sm and RNP serological
immunorecognition (Figures 7 and 10). While sm sera precipitate all snRNP
components, only two of these labeled peptides, A and C, appear in RNp
immunoprecipitates.
An understanding of the peptide antigen recognition by Sm and RNP sera
is of considerable value in light of the common clinically used assays for
these sera. While RNP reactivity has traditionally been distinguished from
Sm by RNase sensitivity in hemagglutination and immunodiffusion assays
(Northway and Tan 1972; Mattioli and Reichlin 1973), it is of interest that
immunoprecipitation of RNase treated snRNP's produces an identical change
in antigen recognition by the two sera. Loss of the A protein
immunoprecipitation occurs for both Shi and RNP sera . W small nuclear
RNA has been shown by Wieben, et. al. (1933) to be critical for A
antigenicity. Ttius, the finding that RNP sera recognize only proteins A
and C may help explain the biochemical basis for the hemagglutination assay
since essentially only C protein reactivity remains for RNP sera in RNase
treated snRNP's. For reasons of valency, 3-dimensional configuration, or
chemical treatments of antigen, the C protein may be poorly reactive in
snRNP particles, in agar diffusion plates (Mattioli and Reichlin 107i) or
when attached chemically to red blood cells (Tan and Peebles 1975)particularly since the most common source of antigen is an acetone extract
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of rabbit thymus. Antibody to C protein may poorly hemagglutinate or
precipitate with antigen under these conditions. If C protein recognition
is not predominant in these assays, then A protein antigenicity would be
the critical recognition for RNP antibody induced hemagglutination or agar
precipitin formation. RNase treatment of snRNP's, then, would be expected
to abolish RNP reactivity. Sm serum's additional recognition of proteins
B, B', D, E, F, and G, however, would still allow for Shi reactivity in

these assays regardless of RNase. Ttiis interpretation is further supported
by the observation that using an ELTSA assay, RNP recognition may be
somewhat diminished, but is by no means abolished by pretreatment of
snRNP's with RNase (W. Reeves, personal communication) . White and Hoch
(1931) have also demonstrated RNP antigen recognition in the absence of
associated RNA from rabbit thymus acetone extract.
Several groups (Kinlaw, et al., 1933; Hinterberger, et al., 19^3) have
reported the isolation of two classes of snRNP particles, one of which
lacks proteins A and C. Tliis class contains the U2-5 small nuclear RNA
species' while the particles containir*g proteins A and C contain Ul RNA.

•Hie other 6 proteins (B, B', D, E, F, and G) are common to both classes of
snRNPs.
In light of the finding that RNP sera recognize proteins A and C only,

while sm sera recognize all 3 components, early reports of the relationship
between Sm and RNP antigens are better understood. Several groups
(Mattioli and Reichlin 19*^1; Northway and Tan 1972; Sharp, et al., 19'^2)
described RNP (also called "Mo") as an RNA containing antigen. However,
fractionation experiments failed to separate it from Sm-reactive material.
This was in contrast to the ability to fractionate pure Sm-reactive

material away from RNP/Shi reactive antigen. Tlius, pure sm-reactive antige
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lik^'ly corresponds to U2-5 containing snRNPs which contain 5 peptides, but
lack A and C. Sm/RNP reactive antigen corresponds to U"!-containing snRNPs
which react with RNP antibodies because of the unique presence in these
particles of A protein (with its associated RNA) and C protein. An
additional noteworthy observation concerns the finding that all an sera
studied contain RNP-like reactivity, an observation v^ich has also been
made by use of immunoblots by Petterson, et. al. (1934) and an ELISA assay
(W. Reeves, personal communication). This clear presence of RNp-like
antibodies in Sm sera raises questions regarding similarities and
differences in the respective disease states. While the determinants on
the A and C proteins recognized by the Sm and RNP antibodies could
conceivably differ, it is striking that both sera lose reactivity with A
after RNase treatment of antigen • Ttius at least one characteristic of
the recognition is common to both sera. Relevant to this question is the

observation of a temporal decrease in the Shi-specific antibodies in two SLE
patients (see Figures 14 and 15).
It is highly interesting that the two peptides (A and C) which
distinguish these particle classes contain the precise antigenic
determinants for RNP sera. Analysis of in vivo particle assembly has
revealed a unique sequence of events v^ich further distinguishes A and C
proteins in the kinetics of their incorporation into newly synthesized
snRNP particles (chapter 5). Taken together, these considerations would
suggest that the immunologic as well as parallel biochemical uniqueness of
A and C proteins are not coincidental.

Figure 5

Sm and RNP sera immunoprecipitate the same radiolabeled peptides

from

15-

hour, ^-methionine labeled cells. K552 cells were labeled in vivo with
with ^^S-methionine for 15 hours, lysed, and the lysate was precipitated
with normal human serim (NHS), 9n serim (lane 1), and RNP serum (lane 2).

1-

Figure 7

Comparison of Sm and RNP inmunoprecipitation of in vitro

generated

srtRNP

proteins. 15 hour ^''s-methionine labeled K552 cell lysate was
immunoprecipitated with Sm serum (lane 1). Tn vitro translation products
of K552 poly A+ RNA were immuno precipitated with Sm (lane 2) and RNP (lane
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Figure 3

Sucrose density sedimentation of native snRNP proteins translated in vitro.
K552 poly A+ RNA was translated in vitro and total products were
fractionated on a 5-20% sucrose gradient. Each fraction was
immunoprecipitated with Sm serum and resolved on a slab gel. The pellet
from the gradient centrifugation was resuspended and immunoprecipitated as
well (lane P). The top of the gradient is indicated on the left. Relative
mobilities of marker proteins are indicated with corresponding S values.
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Figure 9

Titration of methionine starvation for

pulse

labeling

of

srtRNPs.

K=i52

cells were incubated in methionine free medium, and aliquots removed at the
time points indicated (o to 3.25 hours). Such starved cells were then
pulsed immediately with 500 uCi of S-methionine for 3 minutes. Pulse
labeled cells were then lysed and immunoprecipitated with Sm serum.

0

Hours Starvation
0.5 1 1.5 2 3.25

C
D

G

Figure 10

Inmunoprecipitation of pulse-labeled snRNP proteins.
K552 cells were
•75
starved of methionine and then pulse labeled for 3 minutes with
Smethionine. Following cell lysis, the snRNP proteins vere
inmunopreci pita ted with normal human serim (lane 1), 3 different Sm sera
(lanes 2, 3, and "7), and 3 different RNP sera (lanes ^-5).

NHS Sm

Sm

1 2

3

RNP RNP RNP Sm

4

5

7

Figure 11

Splitting of D band in

Immunoprecipitates

with

certain

sera.

15 hour

labeled cell lysates were Immunoprecipitated with two sera. Serum from
patient Tu immunoprecipitates a single D peptide, v*iile the precipitate
usir^ "Mi" serum recognizes two bands in the position of D (see arrows).

Figure 12

Examination of D band

splitting

induced

by

sequential

treatments

with

patient sera. Mixing experiments were carried out on immunoprecipitated
snRNP peptides, adsorbed to protein A sepharose beads. A) Lanes i and 2
show the doublet and singlet patterns of D protein, respectively. Lane 3
contains products of immunoadsorbed, washed. Mi-serum precipitate further
incubated with unlabeled K552 cell lysate plus Tu serum« Lane 4 shows the
appearance of a doublet in Tu-immunoprecipitated D protein when further
treated with lysate plus Mi serum. B) To test whether the splitting
activity is present in the lysate or the serum, an experiment as in "A" was
repeated, but with no lysate added in the second incubation. Lanes 1 and 2
show treatment of precipitates with the same serum. Lanes "^ and 4 show
incubations with the opposite sera. D splitting is observed by serum
incubation alone.
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Figure 13

RNase treatment of in vivo and in vitro generated snRNP's. K552

cells

(A

and C) were grown in S-methionine containing medium for 15 hours followed
by lysis and extraction. (A) Incubation at 3'7°c in the presence (lanes 2
and 4) or absence (lanes 1 and 3) of 1mg/ml RNase A was followed by
immunoprecipitation using RNP (lanes 1 and '>) or Sm (lanes *» and 4) sera.
(B) Translation products of K552 poly A+ RNA were incubated at 25 C for 15
minutes in the presence (lanes 2 and A) or absence (lanes 1 and 3) of 150
ug/ml RNase A followed by immunoprecipitation using Sm (lanes i and 2) or
RNP (lanes 3 and 4) sera. (C) Extract derived from 15 hour labeled K'^'^''
cells was immunoprecipitated onto SPA beads using RNP or Fin sera.
Following 4 washes, the beads were incubated at 37 c with Img/ml RNase A.
Supernatents were removed and beads were washed further. Bound proteins
were eluted and analyzed on a slab gel. Lanes 2 and 4 show material
remaining bound to the SPA beads after RNase incubation for RNP and Sm
coated beads, respectively. RNase treatment supernatents showing a single
A band appear in lanes 1 and 3 for RNP and Sm immunoprecipitations
respectively. The lines at the side of each experiment show the positions
of the A-G bands.
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Figure 14

Change with time in Sm vs. RNP pattern of snRNP recognition in

serim

from

an individual patient. Sera from IP^q through June 10R2 (5/P2) from a
patient with SLE were used to immunoprecipitate snRNPs from pulse labeled
K552 cell extract. A loss of Sm specific bands appears starting between
1979 and 19<?1. The RNP-like recognition of A and C proteins remains
throughout.

Figure 15

Serial changes in snRNP recognition by sera from a

second

patient.

Sera

from February 1977 through July 19^2 were tested for snRNP peptide
recognition usirq pulse labeled K552 cell lysate. An abrupt decrease in 9n
specific reactivity occurred between R/f^O and 10/RO.
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Chapter 4

In vivo Synthesis and Assembly of SriRNPs

ABSTRACT

The in vivo synthesis and assembly of human small nuclear
ribonucleoproteins (snRNPs) have been studied by use of pulse/chase
analysis. Antibodies derived from patients with systemic lupus
erythematosus (SLE) and mixed connective tissue disease (MCTD) recognize
distinguishable subsets of pulse labeled snRNP peptides. Ttiese antibodies
were used to immunoprecipitate sucrose gradient fractionated pulse-labeled
and pulse/chased snRNP proteins. The results indicate that assembly of the

anti-RNP reactive (Ul) snRNP is a two-step process involving prior assembly
of a 5S core particle. Furthermore, a post-translational modification of
one of the lOS snRNP specific peptides has been observed, and the kinetics
of this process indicate that the modification occurs after particle
assembly. Functional and structural implications of a protein core for
snRNP particles are discussed.
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RES'JLTS

Immunoprecipitation of Pulse/chased snRNPs.
To explore in vivo events in the assembly of snRNPs, pulse-chase
analysis of snRNp biosynthesis was undertaken. K552 cells were pulse
35
labeled for 8 minutes in

S-methionme and then

resuspended

in

complete

medium (containing nonradioactive methionine). Ttiroughout further
incubation, aliquots of jxilse/chased cells were removed at 0, 0.2, 1, 5,
and 15 hours of chase. Cells from each time point were lysed and snRNPs
were extracted. Following centrifugation to remove insoluble nuclear
material, the extract was subjected to immunoprecipitation by anti-Sm and
anti-RNP antibodies, derived from sera of patients with SLE and MCTD,
respectively. The results of such pulse-chase analysis are illustrated in
Figure 15.
Directly following pulse labeling (0 chase), anti-Sm antibodies
precipitate all 8 peptides A-G, while anti-RNP antibodies precipitate
labeled snRNP proteins A and C only. Following increased periods of chase
the pattern of proteins precipitated by anti-Sm remains essentially the
same; all eight peptides are precipitated throughout the chase periods.
Anti-RNP antibodies, however, are seen to coprecipitate all eight labeled
peptides only after several hours of cold chase. By f> hours, clear
evidence exists of bands B and B*, and by 15 hours all R peptides are

visualized. Ttiis eventual coprecipitation of all snRNP particle components
by RNP antibodies suggests that de novo snRNP particle assembly occurs in
the time-course of such p)ulse/chase experiments.

Sucrose gradient fractionation of pulse/chased snRNPs.
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Since de novo

assembly

appears

to

occur

within

these

15 hours,

analysis of this process was undertaken utilizing sucrose gradient
centrifugation. K552 cells were pulse labeled or pulse labeled and cold
chased for 15 hours. Tliese two cell sources ("pulse" and "chase") were
lysed, and their snRNPs extracted as above. The extracts were loaded onto
5-20% sucrose gradients and subjected to centrifugation for 20 hours at
41,000 rpm in an SW50.1 rotor. Gradients were then fractionated, and each
fraction was immunoprecipitated using anti-Sm and anti-RNP antibodies. Ttie
four immunoprecipitation patterns generated by this analysis are shown in
Figure 17.
Anti-RNP immunoprecipitation of "pulse" gradient-fractionated extract
is shown in Figure 17- "Pulse-RNP." Of the snRNP proteins, only
radiolabeled A and C appear. A small amount of C protein is present near
the top of the gradient migrating with sedimentation of less than 4S, and
proteins A and C are both present in fractions of approximately lOS. This
pattern suggests that immediately following an 9 minute pulse some of the
newly synthesized C protein exists in an uncomplexed form (<4S) while some
35
newly

synthesized

C protein also exists in a complex ("lOS) in which

S-

labeled A protein is also present. A complex containing all 8 snRNP
proteins with similar mobility has been observed in products of in vitro
translated snRNP proteins (see Figure 8, chapter 3). Itie presence of U.,
RNA in a lOS particle has also been reported (Lerner, et al., 1980).
The pattern obtained from pulse gradient fractionated extract
immunoprecipitated with anti-Sm antibodies is shown in Figure 1*7- "pulseSm." As with anti-RNP antibodies, following pulse, C protein is present
primarily in two forms, one of <4q , the other of about lOS. Radioactive A
protein is again seen in the lOS fractions suggesting that this higher
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mobility

form

of

A

and

C

is due to the presence of a complex in those

fractions. In contrast to the anti-RNP patterns, however, an additional
form of snRNP proteins is present in the anti-Sm immunoprecipitates. in
the fractions of approximately 5S, snRNP proteins D, E, F, and a are
clearly present. Ttieir coincident sedimentation rate suggests that these
peptides also reside in a complex of about 5S. A similar snRNP complex
containing these same peptides has also been observed in products of in
vitro translated snRNP proteins (Figure 8, chapter 3; the appearance of A
protein in 5-''S fractions in Figure 8 probably does not reflect its
presence in a snRNP particle because RNP immunoprecipitation of such in
vitro translation gradients reveals A protein alone in the same 5-7s
fractions). Anti-RNP antibodies appear to lack reactivity with peptides
other than A and C, v^ich explains absence of the 5S complex in Figure 14"pulse-RNP." The bottom fraction in Figure 14- "pulse-Sm" contains a band
(see asterisk) of uncertain identity with mobility somewhat greater than
the D peptide.
Analysis of fractionated "chase" cell extract immunoprecipitated with
anti-RNP is seen in Figure 14- "chase-RNP." The C protein is again seen to
•^5

be present in the upper two fractions (<45).

Additionally, all eight

s-

labeled snRNP particle proteins (A-G) are seen in fractions (10S)
corresponding identically to those in Figure 14- "pulse-RNP" which contain
labeled peptides A and C only. The identical migration of these "pulse"

and "chase" lOS fractions suggests that the same eight proteins are present
in each case, although only A and C are present in labeled form following
brief pulse, of additional interest is the presence of 2 high molecular
weight proteins (greater than 50 kd) near the bottom of the gradient (see
arrows). While likely antigenic for the serum used here, they appear to be
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distinct from snRNPS and migrate broadly as a complex of >10S.
Anti-Sm immunoprecipitation of fractionated chase lysate is shown in
Figure 14- "chase-Sm." Some C protein is again seen in the top two
fractions with a sedimentation rate of <4S. While bands D, E, F, and C,
are present in the "^S fraction (as in the "pulse" lysate, see Figure 14"pulse-Sm") , the lOS snRNP complex is seen to contain all 8 snRNP proteins
in labeled form. No additional labeled peptides appear in the "lOS
fractions which contain snRNP proteins A-G. Ttie presence of all eight
labeled snRNP peptides in the lOS fraction suggests that particle assembly
has occured since the pulse analysis, in which peptides A and C were the
only labeled sp>ecies which migrated at lOS.

Post-translational modification of C protein.
An additional observation relates to the mobility of C protein after
pulse and chase. Comparison of the 15 hour chase an lane with the 0 chase
RNP lane (Figure 15, see arrows) reveals a distinct change in C peptide
mobility. Immediately following pulse, the peptide has a greater mobility
than after chase with evidence for a shift in mobility present within 1
hour of cold chase. The shift appears to be complete by six hours. When

pHilsed material is compared to the 15 hour chase, R^ analysis would suggest
a shift in mobility corresponding to approximately 1000 d. preliminary
39
attempts at analysis of this modification did not demonstrate
P
incorporation following ^^^p-orthophosphate labeling of K552 cells and 0.1
NaOH incubation of washed immunoprecipitates did not appear to alter the
modified C protein (data not shown).

Changes in D protein.
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Of further relevance is the appearance in Figure 14- "chase-RNP" of

D

band as a doublet. Sera from certain patients have consistently given this
pattern of two D bands, while others have not. Figure 14 illustrates the
observation that both of the split D bands are intrinsic snRNp components.
Implications of this split pattern were discussed further in Chapter "^.

Cell fractionation and snRNP assembly.
In an attempt to analyze aspects of the cellular localization of snRNp
particle assembly, pulsed and pulse/chased cells were subjected to
fractionation. The two types of labeled cells were lysed in hypotonic
buffer, nuclei were pelleted by centrifugation, and the cytosol fractions
were removed. Ttie nuclear pellet was extracted with 0.2 M NaCl. Labeled
snRNP proteins in the cytosol and the nuclear extract were
immunoprecipitated using anti-Sm and anti-RNP. Anti-Sm precipitates all P
labeled peptides from cytoplasmic fractions of both pulsed and pulse/chased
cells (Figure 18, lanes 1 and 2). Anti-Sm precipitation of nuclear
fractions, however, reveals only labeled A and C peptides following pulse
(Figure 18, lane 3), but again all eight peptides following chase (Figure
18, lane 4), Anti-RNP precipitates contain only labeled A and C from
pulsed cytoplasmic and nuclear fractions (Figure 18, lanes ^ and 7), v^iile
all 8 snRNP peptides are precipitated by anti-RNP following chase- both in
cytoplasmic (lane 5) and nuclear (lane «) fractions. The observations from
Figure 17 suggests that pulse labeled A and C proteins reside together in a
~10S particle containing the other unlabeled preexisting snRNP proteins.
The results illustrated in Figure 18 demonstrate that pulse labeled A and C
can be seen in cytoplasmic fractions where other snRNP peptides reside
(presumably as a ~5S form- see Figure 17). However the pulse labeled
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nuclear fraction contains A and C as the only radiolabeled
Since

these

snRNo species.

peptides reside in a "lOS form (the presence of <'^S C peptide

is uncertain in the nucleus) , these results
pulse, snRNP

proteins

A

and

C

have

suggest

that

after

a brief

assembled together with the other

unlabeled snRNP species into a lOS particle some of which is present in the
cytoplasmic fraction, but a good deal of which can be found in the nucleus.
Finally, Figure 18 again illustrates the presence of
modification

of

C

a

protein. The changing mobility of C peptide with pulse

and chase is quite evident. Nuclear versus cytoplasmic
protein

appears

post-translational

not

to

correlate

with

the

origin

of

the

C

presence or absence of the

modification.

DISOJSSION

Three forms of snRNP proteins.
While problems related to coprecipitation have
immunologic

analysis of

specificity using autoimmune sera, this same property has been

of great value in
gradient

hampered

studying

analysis

of

assembly

snRNP's

of

the

snRNP

particles.

incubated for 15 hours after a brief pulse

reveals labeled snRNP proteins in three recoverable forms from
cell.

The three

forms are <4S, ~5S, and ""lOS (Figure 17).

appears to represent
(Lerner, et

a mature

snRNP

particle

the

The 10S form

characterized

by

others

contain

the

other

U

The 5S fractions may include particles

series

RNA's (U2, U4, U5, and U5), based on

purification and characterization of this second class of
by

within

al., 1980; Hinterberger, et al., 1903; Kinlaw, et al., 1983)

and demonstrated to contain Ul RNA.
which

Sucrose

Hinterberger,

snRNp

et al. (1Q83) and Kinlaw, et al. (1^83).

particles

proteins n, E,
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F, and G are clearly present in the 5S particles.

Peptides B and B', while

not visualized here, have been suggested to reside in the U2, U^, U5, and
U5 snRNP fraction. The third form of snRNP proteins found in vivo
sediments at a low S value and likely represents unassembled snRNP protein.
Only the C protein is seen in this form. Since A protein antigenicity is
lost (Figure i"^. Chapter 3) (Wieben, et al., 1983) or greatly reduced
(Petterson, et al., 1984) in the absence of U1 RNA, it is uncertain whether
significant quantities of this peptide exist in unassembled form within the
cell since they may not be precipitated by these antibodies. However, no
significant quantities of unassembled (low S value) B, B', D, E, F, and G
proteins were recoverable from K552 cells (Figure 17). Under comparable
biochemical conditions, such low S value forms of proteins B-G were all
recoverable from in vitro translated snRNP proteins (Figure 8, Chapter '^),
suggesting that the peptides other than C protein would not have been
missed due to instability or lack of antigenicity in the unassembled state.
Sucrose gradient analysis of in vivo pulse labeled snRNPs (Figure i"')
has also revealed three forms of these peptides. 1t»e <4S and •'5S forms
appear indistinguishable from the snRNP's after a 15 hour pulse/chase.
However, the third fraction which has identical mobility to the lOS chase
fraction, contains only proteins A and C in labeled form. Most of the
other snRNP proteins (D, E, F, and G) all of which are recognized
individually by anti-Sm antibodies, reside only in the "5S fractions
immediately following pulse labeling. Ttiese labeled proteins appear in the
10S particle, however, following cold chase incubation. On the basis of
their identical sedimentation rate, it appears likely that the two lOS
snRNP fractions (pulse and chase- derived) are actually the same with
regard to protein (and RNA) composition. Only A and C are present in
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radiolabeled form following brief pulse.
the other

snRNP

peptides

are

It therefore appears

assembled

into

Since

the

only

while

smaller particles (~5S),

proteins A and C have associated with these other components
form.

that

in

unlabeled

other identified state of these proteins is a "'5s

particle (Figure 17), it appears likely that newly

translated

proteins A

and C associate with a preformed ~5S particle containing the other peptides
found eventually in the "lOS snRNP.

Two-step model of Ul-snRNP assembly. Taken together, these data imply
an

ordered

sequence of events in the biosynthesis and assembly of snRNPs.

These events involve the formation of a
further

to

become

a

lOS

particle

~5S

particle

(Figure

19).

which

is modified

By this model, newly

translated snRNP proteins are assembled into a 5S "core" particle prior
the

addition

to

of proteins A and C- which is associated with transformation

into the lOS particle.
This two step assembly
protein

constituents

process

of

is based

entirely

on

analysis of

snRNPs. However, based on studies by Lerner, et

al., 1980, Hinterberger, et

al.,

(1983),

and

Kinlaw,

et

al.,

(1^83),

certain correlations of these patterns with RNA components can be proposed.
TVo sets of snRNP fractions with similar protein compositions to the 5S and
lOS particles

described here have been isolated by these groups and shown

to differ in RNA content.
previously

Ttie lOS snRNP

particle

has

(Lerner, et al., 1980) to contain Ul RNA.

demonstrated

particles similar in

protein composition to the 5S particle contain U^r U^r
nuclear

been

^c,' ^^

"^

small

RNAs. Antigenicity of the A protein appears to require associated

Ul RNA (Wieben, et al., 1983), and RNase

treatment

releases

the

peptide

from snRNP particles (Figure 13, Chapter 3). In light of these results, it
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is very likely that the assembly of the

los

snRNP

(where

A

protein

is

clearly seen) from the 5S core involves Ul RNA addition as well as the
presence of A and C proteins. It is unclear v^ether the 5c; core v^ich
serves as precursor to the lOS snRNP contains U2, U-fl, U5, or U5 RNA's or
an RNA-free protein particle. TV/o proposed schemes for such assembly are
shown diagramatically in Figure "^O. While the sucrose gradient analysis
employed in this study would not distinguish 5S particles which lack RNA
from those which contain RNA (if both populations were present, together),
ion exchange chromatography has recently suggested the presence of 2 pldistinguishable populations of particles with protein composition similar

to that of the 5S fraction in Figure 17 (data not shown) . Such an RNA-free

core might also serve as precursor to the non-Ul snRNPs, by the addition of
the respective RNA species'. Kinlaw, et al. (1983) and Mimori, et al.
(1984) have described at least one peptide thoi^ht to be unique to U2containing snRNPs. If all snRNP assembly proceeds via a 5S core precursor,
then the addition of U2, U4, U5, and U5 RNAs would occur together with the
addition of any of these non-Ul snRNP specific proteins. If the core
precursors contain any or all of the U^ ^ species, transformation to the

lOS snRNP would require loss of U^_^ RNA as well as addition of U. RNA, and
the A and C proteins.
The results of cellular fractionation studies (Figure 15) are
consistent with several reports (Elcieri, 1974; Zieve and Penman, 1975;
Elcieri, 1980; DeRobertis, et al., 1982; Madore, et al., 1984) which
suggest that assembly of the Ul-snRNPs occurs in the cytoplasm. By these
proposals, precursors to the mature Ul RNA species are transported to the
cytoplasm where further processing and presumably ribonucleoprotein
assembly occurs. Ttie presence of labeled A and C proteins in the
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cytoplasmic fraction of pulsed cells (Figure lo, lane i) is consistent with
the notion that these represent newly assembled lOS particles which have
not yet migrated to the nucleus. Some of the newly formed lOS snRNP is
also found in the nucleus following pulse (Figure 1«, lane 3) consistent
with rapid assembly and transport. However, it should be noted that all
cellular fractionation experiments may be complicated by leakage between

compartments during the fractionation procedures (Scheele, et al., 1Q78).
The above fractionation data are consistent with cytoplasmic assembly,
35
particularly

because

the

S-labeled A and C peptides are already seen in

the nuclear extract (as well as cytoplasmic) following pulse. Nonetheless
all other possible assembly routes can not be excluded from these data.
Several additional important aspects of this assembly process remain
to be understood. A 5*^,000 d protein reported to be associated with the
snRNP (White and Hoch, 1981; Hinterberger, et al., 1983, Kinlaw, et al.,

1983) has not been visualized in these experiments. Ttjis protein has bee

inconsistently and nonquantitatively seen by immunoprecipitation (Kinlaw,
et al., 1982). An anti-RNP monoclonal antibody (Billings, et al., 1Q82)
recognizes a doublet near 58,000d. A high molecular weight doublet
probably distinct from that one is seen by immunoprecipitation using the
anti-RNP serum shown in Figure 17- "chase-RNP." Ttiese same peptides are
also recognized by certain Sm sera while many anti-RNP sera lack the

reactivity (Conner, et al. 1982). Ttie monoclonal antibody of Billings, e

al. (1982) also recognizes a smaller peptide which may account in part fo

its snRNP recognition. Ttie 58,000 d peptide may associate transiently in
snRNP particles (Kinlaw, et al., 1982), accounting for the difficulty in

reproducibly immunopreci pi tat ing it. Further analysis of this and othe
high molecular weight antigens will be of great interest in further
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elucidating structure and function of snRNPs and other antigen-autoantibody
systems.
Several implications may follow from the observation of two step snRNP
assembly. The possibility exists that the modifications of the core
precursor which convert it into the mature lOS snRNP comprise the addition
of regulatory and/or specificity elements. One example of such a corecontaining multisubunit species is the highly regulated RNA polymerase
complex in e. coli (Chamberlin, 1974). By analogy, the addition of several
peptides and ui RNA to the snRNP core precursor may confer regulatory or
specificity functions resulting in specific enzymatic activities, the best
studied being RNA splicing (Lerner, et al., 1980). Based on their protein
compositions (Hinterberger, et al., 1983; Kinlaw, et al., 1983) the non-Ul
snRNP particles appear likely to contain a similar protein core. "rf an
RNA-free protein core serves as precursor to all classes of U-RNA
containing snRNPs, the addition of other proteins and a specific RNA moiety
would be of paramount importance in determining any functional properties
of the particles. An intrinsic catalytic activity of the RNA such as
described in the tRNA processing species RNase P (Guerrier-Takada, et al.,
1983) might explain in part the apparent specificity of only the Ul
containing snRNPs for mRNA precursor splicing events (Yang, et al., 19<^1;
Padgett, et al., 1983).
In relation to the autoantibody specificity of SLE and MCTD patients
it is of interest that a striking feature v*iich distinguishes the Sm and
RNP serologies is their nonexclusive versus exclusive recognition and
immunoprecipitation of proteins A and C from among all the snRNP proteins.
While sm sera bind components of the core precursor as well as proteins A
and c, RNP sera lack any core particle reactivity (see Figure 17). itiese
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differences in core pjarticle recognition may correlate with differences

in

SLE and MCTD disease manifestations. Perhaps some unique aspect of the
state of these snRNp peptides within the cell relates to their unusual
recognition by the immune system in disease states.
A final set of observations is the discovery of a post-translational
modification of the C protein and an uncharacterized modification in D
protein mobility which occurs in a serum specific fashion. The splitting
of D protein which is observed following immunoprecipitation with some, but
not other anti-snRNP sera, likely relates to an integral snRMp particle
component (Figure 17). This shift in mobility may be the result of the
addition or removal of some chemical moiety frcxn the D peptide during the
immunoprecipitation process. Ttie nature of the moiety remains to be
determined.
Ttie other observed snRNP modification involves a shift in mobility of
de novo synthesized C protein as revealed by pulse/chase analysis. While
R^ analysis would suggest a modification corresponding to "looo d, the
possibility remains that, based on charge properties, the modification may
be much larger or smaller (Weber and Osborn, 1975). An intriguing aspect
of this change in C protein is the observation that based on pulse/chase
analysis, the modification appears to occur after the C protein (or at
least some fraction of it) has been incorporated into the lOS snRNP
particle. In this regard, it is of further interest that some labeled C
protein is present in unassembled form following 15 hours of cold chase.
Since this form is likely to contain the modification (all C appears to be
modified in Figure 15) , the possibility exists that the unassembled,
labeled C protein in chase extracts is material once contained in the 10S
particle. As such, this peptide may be capable of particle dissociations

-^^-

and reassociations, again reminiscent of a class of factors represented

by

rho and sigma and their regulatory functions for the core enzyme of RNA
polymerase (Chamberlin, 1974). Further understanding of the chemical
nature of this modification may help elucidate functionally important snRNP
properties.

Figure 15

SnRNP assembly as revealed by pulse chase time

course.

K5^2

cells were

pulse labeled with S-methionine for 8 minutes. To chase, the pulse
labeled cells were resuspended in medium containing unlabeled methionine.
Aliquots were removed at 0, 0.2, 1, ^, and 15 hours of cold chase, snRNPs
were extracted and immunoprecipitated using anti-Sm and anti-RNP autoimmune
antibodies, as indicated. Ttie two arrows point out a post-translational
modification of the C peptide.

Figure 17

Sucrose gradient analysis of pulse and pulse/chased snRNPs reveals £ 2 step
assembly process. "Pulse-RNP") 8 minute S-methionine pulse labeled K'=i52
cells were extracted and their snRNps fractionated on a 5-20% sucrose
gradient. Fractions were immunoprecipitated using anti-RNP antibodies and
protein A sepharose, followed by elution and resolution by SDSpolyacrylamide gel electrophoresis. Standards for the sucrose gradient are
human hemoglobin (>'.2S), IgG (7S) , and catalase (US). Ttie direction of
the gradient (top to bottom) is indicated as left to right. Ttie snRNP
peptides A and C are indicated in the margins. "Pulse-Sm") Aliquots of the
same fractions used in "Pulse-RNP" were immunoprecipitated using anti-^^
antibodies and analyzed by SDS-polyacrylamide gel electrophoresis.
35
Proteins

A-G

are

identified in the margins.

"Chase RNP")

8 minute

S-

methionine pulse labeled K552 cells were subjected to 15 hours cold
methionine chase at 37°C. Such cells were extracted and their snRNPs
fractionated on a 5-20% sucrose gradient in parallel to the gradients shown
in "pulse-Sm and RNP." Fractions were immunoprecipitated using anti-RNP
antibodies and resolved by SDS-polyacrylamide gel electrophoresis.
"Chase-Sm" ) Aliquots of the same fractions used in "Chase-RNP" were
immunoprecipitated with anti-Sm antibodies and resolved by SDSpolyacrylamide gel electrophoresis.

Figure 18

Newly assembled lOS SORNP is localized in the nucleus. Pulsed

K552

cells

(P) and pulse/chased cells (C) were fractionated by hypotonic lysis (as
described in exp>erimental procedures). SnRNPs derived from nuclear (Nir)
and cytoplasmic (CYT) fractions were immunoprecipitated with anti-Sm and
anti-RNP antibodies as indicated. SnRNP proteins A-G are identified in the
left margin.

CYT

NUC

•ITMPN
CYT

NUC

P C P c
B
B'

1 2 3 4 5 6 7 8

i

_<;Q>

Figure IQ

Scheme for assembly of the protein constituents of the lOS (Ul) snRNP.

A AND C PROTEINS

NEWLY TRANSLATED ^
SNRNP PEPTIDES

^> SS CORE

?^^

>

lOS SNRNP

Figure 20

Two models for the role of U RNAs in the assembly of snail nuclear
ribonucleoproteins.
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Chapter 5

Towards Isolation of cDNA clones for snRNP Proteins

ABSTRACT

An expression vector library has been constructed in the bacteriophage

lambda gtll. RNA was derived frcxn the human cell line 2°"^, which expresse
snRNP proteins similarly to other studied cells. The library contains 40%
5
recombinants

and

contains

1.75

X

10

recombinant m€mh>ers. Preliminary

screening using anti-Sm serum of 250,000 such recombinants revealed ^4
prospective candidates, nine of which were still positive on secondary
screening. Further analysis of these clones may provide isolates of CDN'A
clones for the snRNP proteins.
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RESULTS AND DISCUSSION

A Strategy has been devised for isolating cDNA clones encoding the

various snRNP proteins. Ttie system of choice was bacteriophage lambda gtll
(Young and Davis 1983). Ttiis vector offers the opportunity to screen for

the desired clone with antibodies, because the insertion site is within the
B-galactosidase gene- an inducible gene in e. coli. Ttie method for
generating a library and screening is presented in materials and methods,
however a brief description will be given here.
Twice poly A+ selected RNA from the human tumor cell line 2^3
(prescreened for snRNP expression by immunoprecipitation) , was reverse
transcribed followed by second strand synthesis, linker ligation, and
ligation into Eco Rl cut lambda gtll DNA. The insert-containing phage DNA
was packaged into phage particles followed by infection of e. coli. Ttne

bacterial strain used for screening contains lac deletions so that there is
no background of B-galactosidase synthesis. Plating out a recombinant
lambda gtll library on lac" bacteria in the presence of X-gal generates
blue and colorless plaques. The blue plaques retain intact B-galactosidase
and likely represent ligation of lambda arms back to each other. The
colorless plaques, however, likely represent recombinants in which a cDNA
has ligated to the lambda DNA (within the B-galactosidase gene). Ttie cDNA
effectively interrupts the B-qalactosidase gene preventing its
corresponding enzymatic action on the substrate analogue X-gal. Ttie 2Q3
library obtained by these procedures contains -^0% cx>lorless plaques
(corresponding to 40% recombinants). Ttie library contains a total of 1.75
5
X 10 such recombinants.
Expression vector screening in lambda gtll contains several useful
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properties

relative

to

other

expression

vector

systems.

Being

a

bacteriophage, one generates plaques by infection rather than transfection
(for plasmid vectors). Infection is generally at least an order of
magnitude more efficient and thus larger libraries are usually obtained
with phage vectors. The lambda gtll phage in particular has an aspect of
its screening designed to circimvent a potential hazard in expression
vector cloning. Expression of a hybrid protein (B-galactosidase

interrupted by the cDNA) may on occasion be toxic to the infected bacterial
cell- preventing the formation of a screenable plaque and effectively
leading to loss of that particular clone. To screen lambda gtll, a
bacterial strain Y1090 is used, containing a plasmid which expresses the

lac Iq gene which acts as repressor for B-galactosidase operon- effectively
blocking synthesis of any hybrid (and possibly toxici proteins. After
plaques have grown for several hours, nitrocellulose filters presoaked in
IPTG are overlaid onto the plate. IPTG binds the repressor, leading to
derepression, or expression of B-galactosidase plus any inserts. After
several hours of further incubation, any hybrid protein should have been
synthesized and some should be bound in replica form to the nitrocellulose
1 25
filter.

Ttie filter is then screened with antibcyiy and ' T-protein A, and

any positive plaques are further studied.
Screening was carried out for approximately 250,000 colorless plaques.
Forty four areas were picked from primary screens and following secondary
screening nine possibilities remain. Ttie very low nimber of prospective
positives likely relates to the fact that only one out of six recombinants
could be expected to have ligated in both the correct reading frame and
orientation for proper expression. An additional c:oncern in relation to

the snRNP proteins, is that antigenicity of most of these peptides is quite
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sensitive

to denaturation

(most

snRNP

peptides are not seen on Western

blots- using these same anti-Sm or RNP sera). While not complete, these
studies may provide first steps towards isolation of cDNA clones of snRNP
proteins.
Chapter 5

Summary and discussion: SLE and autoimmunity- a proposal

Analysis of the antigens reccygnized by the f^ and RNP sera seen in
autoimmune disease have suggested the following. Ttiese small nuclear
ribonucleoprotein particles consist of two classes- one containing W RNA
in association with 8 proteins (A-G), the other lacking proteins A and C
while presumably containing U2, U4, U5, and U5 RNAs. Only the Ul snR^TP is

recognized by anti-RNP serum antibcx5ies, because these antibodies recogniz
snRNP proteins A and C only. Sm sera react with both snRNP particle
classes due to the ability of these antibodies to recognize each protein
component (A-G). Recognition of the A protein is sensitive to RNase
treatment for both sm and RNP sera. T\fo patients have been observed to
undergo a change in serum antibcx^y from Sm towards RNP-like recognition
over the course of time.
Use of the antibcx3y reagents has been of considerable utility in
determining aspects of snRNP biochemistry and assembly. Each snRNP protein
was observed to be the prcxiuct of translation from a unic^e mRNA species.
Pulse-chase analysis revealed assembly of Ul (10S) snRNPs to be a 2 step
process involving prior formation of a 5S core particle, followed by the

addition of A and C proteins, 'fliese experiments also revealed the presenc

--7/1_

of one and possibly a second post-translational modification of snRNP
proteins C and D (respectivelyi . The mcx3ification of C protein follows
(kinetically) assembly of this species onto the los particle. The second
mc5dification is observed by the action of a serum component on the C
protein and remains undefined at present.
A series of apparent coincidences among these results may bear
mention. Specifically, the unique metabolism as well as immunologic
recognitin of A and C proteins is perhaps of broader significance. Ttiese
proteins are uniquely added in the second step of Ui snRNP assembly, but
are also uniquely (and exclusively) recognized by anti-RNP antibcx^ies as

well as antibcx3ies in certain Sm patients who have switched to a RNP-like

pattern of recognition. Furthermore one of these two peptides ( D protein)
is the only snRNP protein recoverable from cells in a detectable
unassembled form. The other species (A protein) uniquely requires Ul RNA

for antigenicity. As such unassembled A protein is not likely to have been
detected even if present. Perhaps metabolic aspects of the handling of
these peptides are related to either their presentation or immunologic
recognition in autoimmune disease.

* * *

The following is a proposal which relates immunologic recognition to
the problem of autoimmunity. Vfliile not dealing specifically with any

antigen systems in disease, these ideas may be of some interest on a wider
scale.
The two observations which serve as the starting point for this
proposal are:
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1) the vastly disproportionate occurance of
males

(~9:1),

as

well

as

frequent

SLE

in

observations

abnormalities in afflicted males (e.g. Klinefelter*s

females over

of

x-chromosome

Syndrome,

Stern, et

al. 1977).

2) several reports of increased HLA-locus compatibility (or
identity) between husbands and wives in association with high incidences of
spontaneous abortion; that is, sharing of these transplantation antigens is
associated with maternal difficulty in successfully bringing a pregnancy to
term (Faulk and Mclntyre 1981; Komlos, et al., 1977. Beer,

et

al., 1981;

Gerencer, et al., 1979).

While a relationship between these two observations is not overtly
apparent,

an

attempt

second observation.
been
other

to

draw

one will be made here, beginning with the

The maternal-fetal immunologic relationship

long

problematic for immunologists because a fetal "graft," in cx>ntrast to
allografts

(e.g.

histoincompatibility.

skin,

kidney)

husband-wife

clearly

survives

despite

Ttie fact that identical rejection phencDmena are not

occurring during normal pregnancry is clear,

since

the

vast

majority

of

combinations (couples) and maternal-fetal combinatins are HLA

non-identical. Ttie above observation (#2) would
this

has

incompatibility

maternal-fetal

relationship. While seemingly anomalous, analysis

of

the

components

this

a mechanism could have

perhaps

reveal

vis

how

a

fact, that

the

may

advantageous

in

vis

recognition

is

suggest,

such

of

evolved.
Major histocompatibility gene cc^mplexes (H-2 in the mouse, HLA in man)
were

historically

appreciated

because of properties of allo-recognition.

_-7^-

Ttiat

is, graft

rejection

phenomena

appeared

to

involve

strong

recognition/responses to polymorphisms in proteins encx)ded at these loci.
The striking observation (in the absence of grafts) that polymorphisms of
certain regions within these loci correlate with the ability to mount an
immune response to a given haptene, gave rise to the notion that "immune
r^nse" genes reside as well within these H-2 and HLA loci. Certain
allotypes of these immune reponse gene products (now known as class TT
histocompatibility antigens or la in mouse and Dr in man) were shown to
endow an animal with the ability to respond immunologically to certain
antigens. But "holes" in immune response potential to certain other
defined antigens could be observed if theanimal lacked another (different)
la allotype- one which was associated with ability to respond to certain
other antigens. These experiments suggested that diversity of immune
reponse was in some way related to diversity of la genes- or Dr in man.
Studies of antigen recognition by T lymphocytes revealed the ability (in
fact, the necessity) of T cells to simultaneously recognize H-7 (or HLA) in
association with antigen on antigen presenting cells (see chapter 8). it
would seem reasonable then, to imagine that this la or Dr restrictin in
immune response may be effected biologically at the level of T cell
recognition of antigen (+ H-2/t)r). Furthermore, heterozygosity of the two
alleles for these immune response genes would be expected to provide a
selective advantage relative to homozygosity, because increased diversity
of immune recognition correlates with wider spectrum of antigen
recognition.
If maternal-fetal recognition were to exist such that diversity of H-2
and HLA loci were selected for, one would predict that a population capable
of such "diversity-selection" could have a selective advantage over a
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population lacking such recognition, in this regard then, the observation
that spontaneous, recurrent abortions are frequently correlated with HLA
identity between husband and wife may simply reveal the presence (and
effects) of such a "diversity-selection" mechanism.
Further support for the possibility that such recognition may operate
in the maternal-fetal relationship comes from reports (though mostly
anecdotal) of difficulties encountered during animal inbreeding. Ttiese
difficulties appear to involve low reproductive efficiency of animals when
bred for genetic identity. A further implication of this hypothesis, if

cx)rrect, would be that females in established inbred strains of animals ma

have lost or mutated the gene(s) responsible for this "diversity-selection"
in the process of inbreeding. Ttierefore inbred strains of animals
(generated frequently to test allorecognition) may contain a
(paradoxically, selected for) defect in some aspect of their
allorecognition.
This cx>ncept of alio vs. self recognition in the maternal fetal
relationship carries with it a prop)erty uniquely critical to females.
Maternal recognition of a genetically identical fetus (appearing as
"self") , then, may result in an immunologically mediated reaction to self
(or "nonreaction to self") resulting in spontaneous abortion because of

failure to support such a fetus or due to specific mechanisms which destroy
it. Such properties might well be X-chromosome enc:oded. What has been
described, then, amounts essentially to a female specific recognition of
"self" with subsequent destruction of "self." Such a description bears
remarkable similarity to the scenario encrountered in autoimmune diseaseparticularly diseases such as SLE which are characterized by female
preponderance. Considerable additional evidence has implicated X-
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chromosomal genes in immunologically

critical

activities,

as

seen,

for

example, in x-linked immunodeficiencry disease of man. In summary, then,

this hypothesis would syggest that an immunologically mediated mechanism of
"self" recognition normally present in females may have gone awry in
certain autoimmune disease.
While little has been done to test this idea, one recent report (Schur

and Carpenter, 1983) contributes very useful data (without having addressed
this particular issue). In this study of HLA haplotype (A and B loci only)
correlations in SLE, the only significant observation related to the HLA
types of parents of SLE patients. Of 70 normal parental pairs (controls^ ,

only ~4% shared HLA A, B haplotypes. Of 35 SLE parental pairs {"^^ pairs of
SLE patient parents) , 7 shared A,B haplotype. Ttius 20% sharing was
observed in SLE parents as compared to 4% for normals. Given the known

genetic influence in acquisition of lupus, this shared haplotype phenomenon
may reflect abberant fetal recognition (at some level) by the luous
mothers. Ttiat is normal couples with shared haplotypes may have had less
success in producing viable offspring. A second observation which may in

some manner relate to the above hypothesis involves the observations (Mund,
et al., 1953) of pregnancy's profound influence over the course of disease
activity in lupus patients.
Further analysis of genetic loci possibly Involved in such a
recognition process may in the future be amenable to study by use of
restriction fragment length polymorphisms (RFLP) technology (Botstein, et
al., 1980).
If "diversity-selection" is, in fact a real biological phenomenon, its
biochemical basis would be expected to reside at the level of T lymphocyte
recognition of antigen. Delineation of structures possibly involved in
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this

antigen

recognition

is the topic of discussion for part two of this

thesis.
Part II
Chapter 7

Introduction

Elucidation of structural properties of the T lypmphocyte receptor for
antigen has represented one of the most profoundly elusive problems in
modern immunology. The characterization of numerous functional properties
for T cell subpopulations has helped establish the exquisite antigen
specificity of these cells. Ttie dual nature of T cell antigen recognition
by T lymphocytes was established by the discoveries that antigen
recognition occurs specifically in the context of prcx3ucts of the major

histocompatibility complex (MHC) (Benacerraf and McDevitt 1972; Zinkernagel
and Doherty 1975; Schlossman i<^72). This dual specificity of T cells for
both antigen and MHC gave rise to two theories which may account for T cell
receptor recognition (Zinkernagel 1978). A first model proposes the
existence of two distinct receptors: one specific for antigen and another
specific for MHC. Presumably appropriate binding to both receptors would
serve as antigen recognition. A second model involves the notion of a
single receptor which recognizes a single "antigen" which itself contains
determinants derived from both MHC and real antigen.
Ttie determination of antigen reactivity by T cells has been studied in
vitro by incubation of the T cells with antigen and appropriate accessory
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cells.

Stimulation

by

antigen

has been

measured

by

H-thymidine

incorporation, 11-2 secretion, as well as biological function. Ttie
critical role of accessory cells in helping to generate the T cell
antigenic response has been extablished for some time (Hersch and Harris

1958; Cline and Sweet 1958). Numerous studies have argued conclusively for
the role of adherent mononuclear cells in this activity (Seeger and
Oppenheim 1970; Rosenwasser and Rosenthal 107R), qtie prevailing notion
that the monocyte/macrophage population is primarily responsible for such

cell activation phenomena has recently come into serious question with the

reports of highly potent stimulating capacity for dendritic cells fSteinma
and Nussenzweig 1980) of mouse (Steinman, et al., 1983; Sunshine, et al.,
198"^) and man (Crow and Kunkel 1982; Van Voorhis, et al.,1083). Ttie
relatively weak stimulating capacity of purified monocytes (Steinman and
Nussenzweig 1980) has argued more conclusively for the primary role of
dendritic cells in this T cell stimulation.
Use of an in vitro T cell antigen specific system has recently been
made to provide strong evidence for the "one receptor" theory of antigen
recognition, in these experiments (Kappler, et al., 1981) hybridomas were

derived from two T cells each with specificity for a certain antigen and a
corresponding MHC type. Resulting hybrids were unable to respond to one
antigen plus the other MHC type, but could only respond to the same

combinations of antigen plus MHC as the cells used for fusion. Ttiis resul
argued strongly for the liklihood of a single T cell receptor for antigen
plus MHC.
Considerable attention has been paid to the possibility that the T
cell receptor structure may utilize gene prcx3ucts in common with
immunoglobulin. Specifically, the use of anti-immunoglobulin antibodies
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appeared

to

recognize

T

cell

structures

which

may

relate to antigen

recognition (Binz, et al., 197*=^). This and numerous other reports
suggesting immunoglobulin characteristics of the T cell receptor were not,
however, general izeable and as such did not lead conclusively to
determination of a receptor structure. More recently several laboratories
provided evidence for the possibility that idiotypic structures contained
in the T cell receptor may be derived from the same gene segments (v„) as
n

in the case of antibody heavy chain (Binz and Wigzell 1977; Rajewsky and
Eichmann 1977; Krarrener 1981). Other groups (Hammerling, et al., 1Q''5;

Bach, et al., 1979; Mozes and Haimovich 1979; Suzan, et al., 1^81; Owen, et
al., 1931) described genetic linkage of T cell antigen recognition
structures to the immunoglobulin heavy chain locus. CVen, et al. (1^79^
1981) furthennore mapped the putative recognition structures to the mouse
chromosome 17 between the Igh-1 locus (encx>ding cx)nstant region genes of
immunoglobulin heavy chains) and the prealbumin gene. Similar
alloantigenic molecules were observed as secreted T cell products
(Taniguchi, et al., 1982; Tokuhisa and Taniguchi 1982). A number of
studies, however, have demonstrated lack of shared gene prcx^ucts for
immunoglobulin and the T cell receptor for antigen. Immunoglobulin joining
and constant region gene transcripts could not be detected in T helper or
killer cells (Kronenberg, et al., 1980). Furthermore, the use of gene
probes derived from v„ gene segments and presumed to be capable of very
H
wide recognition of v„ genes failed to detect homolagous transcripts in T
n

cells (Kronenberg, et al., 1983) even when V„ probes were derived from B
H
cells with the same antigen specificity as the T cells (Kraig, et al.,
1983). Thus, although the possibility remains that shared determinants may
exist for immunoglobulin and the T cell receptor, sharing of actual gene
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segments appears to be unlikely.
Considerable advances have recently been made in the understanding of
T lympjhocyte populations by application of the monoclonal antibody
technique (Kohler and Milstein 1075) to the study of T cell surface
proteins. Among the more important such markers in humans are the
molecules recognized by the antibodies OKT'', T4, and T8 (Reinherz, et al.,
1983). T4+ T cells appear to recognize class II MHC determinants while TP+

cells recognize class I MHC structures (and the cells bearing these markers
are mostly help)er and c:ytotoxic cells, respectively) . Ttie T'' molecule
appears to reside on all mature T cells and has been implicated as
important in antigen recognition by virtue of the ability of antibody
against this structure to block antigen specific T cell activation. The
considerable specificity of monoclonal antibodies directed against T
lymphocytes may be of further use in delineating important structures in
antigen recognition. It is the use of this methodology which forms the
basis of the analyses of the T cell receptor which follow.

-Q-J_

Chapter 8

T Cell Receptor Structures on TVo T Cell Leukemias

ABSTRACT

Monoclonal antibodies were obtained that displayed unique recognition
of a surface protein epitope on each of two T cell leukemias. Ttiese

reactivities resemble anti-idiotypic antibodies in the specificity of thei
recognition. For each T cell leukemia, a second monoclonal antibody was
obtained which recognized the same molecule as the idiotype-specific
antibodies. Ttiis second set of monoclonals, however, was capable of
staining a certain fraction of normal T cells, suggesting the recognition
of a cross-reactive or constant region determinant. Ttie molecules

identified in these studies are both disulfide-linked heterodimers. One is
70-75 kd unreduced, and contains a crossreactive determinant with ~2% of

normal T cells. Ttie other is 80-00 kd unreduced and contains a determinan
present on 30-5^% of normal T cells. By virtue of immunochemical

properties of these surface proteins, as well as biological effects of the

antibodies directed against them, these molecules would appear to be stron
candidates for the T lymphocyte antigen receptor.

REAGENTS
Ttie strategy for identification of the T lymphocryte receptor for
antigen relies on analcxgy between this putative structure and the B cell
antigen recpetor: immunoglobulin. A clone of B cells would likely share
antibody idiotypic determinants with no other cells. Antibodies directed

against constant region domains of immunoglobulin would, however, be likel
to recognize other B lymphocytes as well.
Ttie antibody reagents used in these studies were mouse monoclonal
antibodies generated by Dr. Robert Bigler and Dr. David Posnett by

immunization of mice with leukemic cells from twD T cell leukemia patients
patient Su
T lymphocytes from this patient were of the Sezary type. Leukemic
cells displayed the phenotype: E rosette +, 0KT3+, 0KT^->-, 0KT«-, la-,
sig-. Following immunization and fusion, two hybridc5mas of interest were
obtained. Surface staining, as measured by indirect immunofluorescence,
revealed one of these antibodies (called SI50) to stain exclusively the
immunizing T leukemia cells. Cells failing to show any staining included:

autolagous and allogeneic normal B and T cells, other T leukemias, myeloid
cells, B and T cell lines, activated normal B and T cells. Thus the SI50
antibody appears to be entirely specific for this leukemia cell.
A second monoclonal antibcxJy (called SVll) displayed nearly identical

staining patterns, with the important distinction that approximately 2% of

normal resting T lymphocytes stained strongly with this antibody. Ttie SVl
antibcxJy therefore recognizes a determinant shared by the leukemic clone

T cells with a small percentage of normal T lymphocrytes, but with no othe
identified cells.
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patient Fi
The immunizing leukemic cells were derived from a T cell chronic
lymphocytic leukemia. F»henotypically the cells were E rosette +, OKT''+,
0KT4+, 0KT8-, la-, Tacf, sig-. From the resulting hybridomas, one (termed

FF25) exhibited exclusive staining of the immunizing cells. All other cell

populations examined including autolagous and allogeneic leukocrytes did n
stain with FF25. Ttiis antibody, therefore, apjpeared to display complete

specificity for the leukemic cell clone. A second monoclonal, termed FFB"^

reacted both with the leukemic cells and 30-50% of normal T cells, as well
as with several T cell lines. A second recently obtained antibcx3y (FFB3)
appears to recognize 30-50% of stimulated normal T cells as well as the
immunizing leukemic cells and is discussed below.

RESULTS
Analysis of the structures against which these various hybridomas were
directed was carried out by solubilization of the appropriate surface
iodinated leukemic cells followed by immunoprecipitation. These results
are shown for the SI50 and SVll antihnDdies is Figure 21. Using Su cells,
lanes 1 and 5 show unreduced forms of SI50 and SVll immunoprecipitates,
respectively. A 70,000 d heavily labeled protein app^s for both

antibodies, upon reduction with dithiothreitol (lanes "^ and 7), the 70,oo

d protein is not seen, but two smaller peptides appear for both antibodies

Ttie smaller component is about 38,000 d and much more heavily labeled tha

the slightly larger 43,000 d species. Analysis of immunoprecipitates using

these same antibodies, but with different cell extracts (T cell line KE37)
are shown in odd numbered lanes in Figure 21. In parallel to the staining
patterns for these hybridomas, no antigenic peptides are visibly
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immunoprecipitated from this T cell source.
Further analysis of the disulfide reduction property of the protein
recognized by these two monoclonals was carried out by cutting out the
70,000 d (unreduced) band from a first gel, rehydrating in buffer
containing dithiothreitol, and electroeluting into a second SDSpolyacrylamide gel. Figure 22 shows the 70,000 d and two lower bands in
lanes 1-3, rehydrated in the absence of reducing agent. However in the
presence of reducing agent (lanes 4-5) the 70,000 d band is directly
converted into the two lower molecular weight bands. It is of some

relevance that the 3*^,000 d band has uniformly appeared much more heavily
labeled than the 43,000 d species. Ttiese differences may arise due to

differing numbers of icx3inated tyrosine residues, or incxjmplete icx5ina
due to membrane properties of the cell. Analysis by 7-dimensional gel
electrophoresis (performed by Dr. C. Y. Wangi has revealed
microheterogeneity for both of these peptides, consistent with
glycosylation patterns.
Numerous attempts have been made to use these two monoclonal
antibodies as aids in obtaining cDNA clones for the molecule under study.

RNA extractions were carried out both by NP-40 lysis and phenol extraction
(to obtain c:ytoplasmic RNA) and guanidinium thiocyanate (yielding total
cellular RNA). One difficulty in working with these leukemic cells is
their extraordinarily small size and their low yield of RNA upon
extraction. Ttie similar RNA yields obtained using guanidinium salt
extractions argues against degradation as the cause of low RNA yields.
Furthermore, oligo dT cellulose chromatography led to the isolation of
under 2 ug of poly A+ RNA from 4 mg of total RNA of the Su cells.
Ttierefore, a very powerful cDNA cloning system was needed given such a
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small cyjantity of starting material. Using the lambda gtio vector a cDNA

library was constructed from Su poly A+ RNA which contained approximately
200,000 members.
parallel experiments were performed to determine a manner which one of
the monoclonal antibodies might be useful in identifying clones of
interest. Attempts at immunoblots (Western blots) failed to display

antibcx3y recognition- likely suggesting considerable detergent sensitivi
of the antigenic determinants. Immunoprecipitation of Su cell extracts
which were previously reduced and alkylated (using iodoacetamidel also
failed to reveal antigen recognition by these monoclonals. A realistic
conclusion from these studies suggests the likihocx3 that determinants

recognized by both monoclonal antibodies in some way require intact linka
of the two chains together, for successful antibody recognition. Such
recognition behavior would be similarly sensitive to reduction and
denaturation in the case of antibodies directed against idiotypic
determinants on immunoglobulin. Inability to immunoprecipitate Su RNA in
vitro translation products using these antibodies further supports this
notion (data not shown).
It therefore became evident that more broadly reactive antibcx3ies to

the same molecule would be of greater aid for further molecular biologica
study.
To that erid, a strategy was devised to prepare a rabbit antiserum

directed against the same molecule. Unlabeled Su leukemic cell lysate was
immunoprecipitated onto protein A sepharose beads which were washed and
immunized directly in Complete Freund's Adjuvant into two rabbits
intraperitoneally. Following 2 months of weekly immunizations, sera were
tested for reactivity by immunoprecipitation but failed to reveal any
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reactive

antibodies.

Immunizations

were

then

continued

using

immune

complexes (as above) this time adsorbed onto formalin fixed staph aureus
organisms. Following 3 months of further immunization, sera were obtained
125
and

used

to

immunoprecipitate

' T-labeled Su cell extracts, as shown in

Figure 2"^. Patterns are seen both for the SVll monoclonal antibody
(positive control) as well as for the rabbit immunoprecipitates, reduce^d
and unreduced. Clear evidence exists for appearance of the identical
protein precipitates, recognized by the rabbit antibodies.
A second monoclonal T cell system was amenable to similar analysis,

with the development of monoclonal antibody FF75, reactive with malignant T
125
lymphocytes

from

patient

Fi.

Immunoprecipitation

of

I-labeled

Fi

extracts with FF25 antibody was carried out alongside immunoprecipitates of

Su cells using SVll antibody. As seen in Figure 24 lanes 1 and '', the FF7^
antibody also recognizes a disulfide linked heterodimer. However, several
clear properties distinguish this molecule from the pattern obtained by
SVll antibody and Su extract (lanes 2 and 4). The unreduced protein from
Fi migrates at about 00,000 d, compared to "•70,000 d for Su. Ttie two

reduced peptides migrate at approximately 52 and 4 3,000 d as compared to ^
and 38,000 d for Su. Both molecules apjpear to contain a heavily labeled
and a lightly labeled ccmponent (see reduced forms, lanes 3 and 4). Ttie
lightly labeled peptides appear to comigrate indistinguishably for the two
cell sources, v^iile the heavily labeled peptides differ considerably in
migration. A second monoclonal antibody, FFB3, has recently been obtained
which shcjws reactivity with not only the immunizing T leukemia cells, but
also 30-50% of normal T cells and several T cell lines. Secguential

immunoprecipitation has indicated (data not shown) that FFB3 recognizes the
same molecule as the idiotype-specific antibody, FF25.
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Towards eventual isolation of cDNA clones for the proteins studied in

Fi cells RNA was extracted and a cDNA library consisting of approximately
100,001^ members was constructed in lambda gtio.
Tise of T cell-specific cT>JA probe
The use of monoclonal antibodies as probes for T cell specific
membrane markers has a theoretical parallel utilizing techniques of

recombinant DNA. Specifically, the generation of a T-cell "specific" prob

would be expected to identify cDNA clones unique to T cells and, perhaps,
including the gene(s) encoding the receptor for antigen.
Attempts at such a strategy have been made utilizing the human T' cell

line HTfr-"'02 from which a 250,000 member cDNA library was generated. Tt
strategy for gene identification involved first generating a T cell

specific CDNA probe (by hybrid depletion) and screening of the Wjv librar
for T cell-specific genes. Putative candidates would be screened by

Southern blot analysis for the presence of a gene rearrangement by analog
with observations in the immunoglobulin genes of B cells.
Generation of T cell-specific probe employed the use of T cell poly A+

RNA and B cell line (IM-9, kindly provided by Dr. Nicholas Chiorazzi) pol
32
A+ RNA.

HUT

P-cDNA was hybridized to IM-Q poly A4- RNA

m

vast

excess.

Single stranded and double stranded nucleic acids were then separated by

use of hydroxyl apatite chromatography. In the presence of 0.1 M phosphat
buffer, only double stranded nucleic acids bind to the colimn. Single
stranded nucleic acids (and presumably T cell-specific cDNAs) are thus
separable in this step, from double stranded forms, v^ich can be eluted
with 0.4 M phosphate. Ttie relative proportions found in single and
double-stranded forms are quantitated by counting the various fractions.

An index of completion for such nucleic acid hybridization reactions is t
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R t value, a number reflecting the influences of both concentration and
o
time on degree of hybridization. In brief, the relationship of R t to
completion of the hybridization reaction is given in the following
derivation.
37
For the hybridization reaction: ( * connotes

TmRNAl + FcDNA*!

K

v

P-labeled)

RNA:cDNA*

If R=fmRNAl and C=fcrNA*l and R » C (reaction is run in vast

excess) , then

the rate of this reaction is given by pseudofirst order kinetics and rate
of disappearance of cDNA with time is:
-(dC/dt)=KRC.
K represents a pseudofirst order rate constant which depends on complexity
and may (in theory) vary among different cell types. Rearranging the above
equation gives:
-(dC/C)=KRTdT
which may be integrated between times t to t and for cDNA concentrations
C^ to C^ to obtain:
o
t
ln(C /C.)=KRt.
o t
Rearrangement of this expression gives:
C /C ^e-"^^
Since R»C, R^ is approximately equal to R . Therefore the equation
describing the rate of disappearance of single stranded cDMA probe shows
the hybridization to be a function of the two variables R (or B cell A+
o
RNA concentration) and t (time of hybridization) . In the case of HeLa cell
poly A+RNA (hybridizing to its own cDNA), hybridization to a R^t of 10^
((mol.s)/l) gave approximately 90% SI nuclease resistant (i.e. double-
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stranded) cDNA-RNA hybrids (Bishop, et al.

1974).

Hybridization

of

HUT

CDNA with IM-9 A+ RNA was therefore carried out to a R Qt
of approximately 28no (with the purpose of driving the reaction as far as
possible) . However, Northern blot analysis of this select probe revealed
very extensive hybridization to B cell RNA. Further B-T hybridizations
were therefore carried out to determine conditions under v^ich a cleaner
(more T cell specific) cDNA probe cx)uld be generated. Figure 75 shows the
proportions of single and double stranded cDNAs following sequential
hybridizations to B cell RNA. Ttiese results indicated that two rounds of
hybridization (R t=500) left cDNA, only 2% of which was capable of forming
hydroxy apetite separable duplexes following a third round of
hybridization. Ttierefore, more cDNA specific probe was generated by 7
rounds of hybridization to IM-o RNA. Northern blot analysis of this probe
appears in Figure 25 and shows considerable enrichment of T cell
reccxgnition over B cell. Reactivity with certain specific B cell RNA
species remained, and is presumed to represent a population of probe
species not amenable to removal by this method.
Such twice-hybridized T cell-select cDNA probe was then used to screen
15,000 clones from the HUT 102 lambda gtll cDNA library. 7/J5 plaques
showed strong binding to this probe representing 1.5% of the clones. An
example of one filter showing about 20 positive clones is seen in Figure

27. Ttiis same filter was a replica of a plate containing approximately 500
total plaques (thus '"4% of plaques were positive on this plate) . Further
analysis of these putative T cell specific clones required that they first
be plaque-purified (that is, purified by 2° screening away from
neighboring, contaminating phage). Having purified approximately ^0 of
these candidates, the first 5 were amplified and tested on Northern blots
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for their T cell specificity.

Ttiese particular Northern blots (Figure 7P)

contained total RNA from both B (IM-9) and T (HUT 102) cell sources. Ttie

unexpected result seen in 3 out of "^ clones tested revealed a heterogeneous
smear of hybridization particularly strong in the T cell lane and
identification of a small RNA species in both B and T cell RNAs (probes 3,
4, and 5). Intactness of the RNAs in these blots was verified by
rehybridization of one of the same blots (after washingi with a separate
probe (Figure 29) for a unique sequence gene (provided by Dr. Hung Teh
Kao), The suspicion that these unusual hybridization patterns may reflect
the presence of repetetive sequences in the probe was tested by
hybridization to one of the same blots (after washing and reexposure to
St 32
ascertain

removal

of

the i

probe) of

"P-labeled nick translated human

gencmic DNA (derived frcxn the Raji cell line) . The result, seen in Figure
30, reveals the identical pattern of hybridization, highly suggestive of a
pattern for repeat sequences within the probe. Ttie small RNA band likely
represents the small RNA 7s which has been shown to contain Alu-type
repetetive sequences (Reddy and Busch 1983).
The presence of repetetive sequences among such putative T cell
specific clones may be the result of a high level of expression in HITT* IO7
of mRNAs containing repeat sequences. As such, the increased expression of
such rep)eat-containing genes (relative to IM-9 c^lls) may perhaps be of
relevance to functional properties of this class of sequences.
Alternatively this expression pattern may represent a relic of
transpositional activity at some stage in the derivation of the HUT 102
cell line and be of little functional significance at present. Methods
could be devised (in principle) to overcome this problem. For example,
random sequence primers for the P-cTNA probe sunthesis could be used in
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conjunction with boiling to break the probe into small pieces. Such a
mixture should contain representations of all the mRNA sequences, but on
nimerous small pieces. A hybridization reaction with genomic DMA should
remove all fragments containing repetetive sequences, while leaving unique
sequence-specific fragments. Such a procedure, however, while
theoretically feasible, would require synthesis of an enormous quantity of
32
P-labeled cDNA starting material- an

exceedingly

difficult

task

using

random cDNA primers. For these reasons, a better approach would likely
involve selection of a different T cell source of RNA- particularly if one
can be found which lacks the high level of repeat sequence expression as in
HUT-102.

DISCUSS THNT
Several monoclonal antibcx3ies have been described which appear likely to
recognize structures with characteristics in common with a pjutative T cell
antigen receptor. Although no direct evidence has been obtained for the
notion that the identified structure is an antigen receptor, considerable
indirect evidence supports this notion. Antibodies directed against
similar disulfide linked heterodimers have been shown to block specific
activities in both mouse and cytotoxic human T cell antigen specific
systems (Meuer, et al., 1983; Haskins, et al., 1083). A co-modulation
phenomenon has also been described (Reinherz, et al., 1982) in which the T
cell receptor complex is postulated to contain several elements, one of
which is the peptide recognized by the OKT'' monoclonal antibody. Tn
modulation experiments, a given monoclonal antibody is bound to target
cells, which are then incubated for 12 hours at 37°c. Upon restaining at
that time, the percent positive cells may decrease for a second antibody.
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if its target surface antigen has "cx>-modulated" off the cell surface
together with the target for the first antibody. Co-modulation is in some
sense considered an index of associations between different proteins in a
cell membrane. By these analyses, the SI50 and SVll antibodies as well as
FF2^ have all been observed to co-modulate with the OKT"? molecule (data not
shown) , further supporting the possibility that these monoclonal antibodies
recognize molecules important in T cell antigen recognition.
Perhaps the most compelling evidence that the targets for these
monoclonals are T cell receptor molecules, is the idiotype-like cfualities
demonstrated by the antibodies. Ttie unique reccxjnition of only a single
clone of T cells (as seen with SI'^O and FF25) is highly reminiscent of
patterns obtained by similar analysis of anti-idiotypic reagents on
monoclonal B cell sources. If antigen recognition requires diversityenccx3ing elements which differ depending on antigen specificity, then the
presence of idiotypic determinants would be a prerequisite for the
expression of such diversity.
Several other groups have described similar monoclonal antibody
systems reactive with T cells in idiotype-like fashion, both in mouse
(Allison, et al., 1982; Haskins, et al., 1083) and humans (Meuer, et al.,
1983) Vfliile the recognized molecules have been identified as disulfide
linked hetercx^imers, the sizes of previously reported molecules have all
been similar to the antigen rec!ognized by FF25. The Su molecule appears
somewhat smaller than the others, and may correspondingly represent a
different i so type for the T cell receptor than has been recognized in the
other systems. Particularly striking evidence that the SVll and FFB"»
recognized molecules are antigen receptors relates to the fact that the
molecules appear to contain both unique and shared determinants- analagous
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to variable and constant domains of immunoglobulin.
The shared SVll determinant demonstrated by binding to normal T cells
of S\^ll antibody, is relatively rare among T cells (""2%1. It should be
noted however, that antibodies directed against constant determinants of
(for example) IgA or IgE would similarly recognize only small populations
of circulating B lymphocytes. Ttie SVll antibody, then, may recognize a
relatively rare isotype (or "class") of T cell receptor molecule. An
alternative type of recognition which may be operating for the S\m
monoclonal is cross-reactive idiotypy, wherein a shared determinant is
recognized from among variable regions of (isotypically) different
molecules. If this were the case, then an antiserum such as that obtained
by the rabbit immunizations (see Figure 23) should provide a vehicle for
the examination of constant region determinants. Antibodies present in
this same serum may as well be of further help in recognition of primary
translation products for the various chains, and as such may assist in
identifying cDNA clones encoding the proteins of interest. Analysis of
structural differences among the molecules on normal T cells reactive with
SVll antibody will be carried out when monoclonal cell lines derived from
that population can be expanded appropriately. At that stage, peptide
mapping and further serologic studies may reveal more information regarding
variable and constant dcxnains of the T cell receptor.
Ttie cross reactive determinant recognized by the FFB3 monoclonal
antibody is present on a large population of normal T cells ('^0-50%). If
this recognition involves a distinct isotype, it would be a relatively

common isotype of T cells (analagous to Tgvi or IgG isotypes among B cells).
An intriguing recent result is the observation that an 80 kd protein which
comigrated with this Fi idiotypic molecule was identified by western

-95-

blotting using a monoclonal anti-HLA antibody.

As with the SI50

and

svil

antibodies, FF2^ and FFB3 display no recognition on Western blotspresumably due to SDS-denaturation. Ttiis HLA monoclonal antibody, however,
reproducibly identifies the 45 kd HLA heavy chain by Western blotting (or
immunoprecipitation). When this antibody is used to probe a Western blot
containing Fi leukemia cell lysate run unreduced, an 80 kd peptide is
visualized (as well as the 45 kd HLA). Ttie higher band disappears upon
reduction- as predicted for the idiotypic molecule. One possible
explanation for these results is that perhaps the smaller peptide in the Fi
idiotype molecule ^is HLA heavy chain. This appears to be unlikely,
however, because immunoprecipitation with numerous anti-HLA antibodies
including polyclonal rabbit antibcxdies never resulted in identification of
the Fi molecule. A second, more likely, alternative is the possibility
that this idiotype molecule contains a determinant in common with HLA, but
one which is not normally exposed in the molecule. SDS denaturation may
expose the determinant on Western blots. Such homology to HLA would not be
unprecedented cmong surface molecules in the immune system (Williams 1OP4),
Further analysis of these possibilities is underway by use of peptide
mapping.
Of particular value is the observation that the FFB"^ antibody binds to
several immortal T cell lines (.lurkat and Cem-T, data not shown) . As such,
isolation of large cpantities of RNA should be easier than was the case for
the 2 leukemia cell sources. Comparison of molecular features at the
protein level will be of equal interest, using these reagents.
Finally, several recent reports (Yanagi, et al., 1084; Hedrick, et
al., 1984a,b) have described the identification of T cell cDNA clones
derived by plus/minus screening or hybrid depletion similar to the
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techniques

employed in the HlfT 102 experiments described here. Ttiese gene

products appear to contain both constant and variable nucleotide sequences.
The molecules encode peptides of approximately ^0-'*5,nnod. Considering
additional glycosylation, as well as strikingly similar characteristics of
specificity, and variable and constant sequences or epitopes, the
intriguing possibility exists that these isolated clones may correspond to
one of the two chains described in these studies using anti-idiotypic
monoclonal antibodies.

Figure 21

Peptide recognition of 5150 and SVll monoclonal antibodies.

I

labeled

Su leukemia cell extract was immunoprecipitated and resolved on a 15% SDRpolyacrylamide gel. Lane 1) before reduction and lane 3) after reduction
for antibody SI50; lanes 5 and 7, before and after reduction for antibody
SVll. Lanes 2, 4, and 5 represent control precipitations with these
antibodies against the KE'^7 T cell line. Molecular weights are indicated
in kilodaltons.
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Figure 22

Direct conversion of the 7n,oood T cell specific

peptide

to

two

smaller

chains by disulfide reduction. Ttie upper band, as well as the twD reduced
bands (as seen in Figure 21) were excised and rehydrated in the absence
(lanes 1-3) or presence (lanes 4-5) of 0.1 M DTT. Lane s demonstrates the
migration of the same protein seen in lane one following disulfide
reduction.

Figure 23

Generation of polyclonal rabbit antiserum to the idiotypic molecule

of

Su

leukemia cells. Immunoprecipitated SVll antigen, adsorbed to formalin
fixed staph, aureus, was injected intraperitoneally into a rabbit for 3
125
months.

Immunoprecipitation

with

the

resulting

rabbit

serum of

" i-

labeled Su cell lysate is shown under reduced (red.) and unreduced (unred)
conditions. Identity of the SVll antigen is seen under the same
immunoprecipitation conditions (SVll, red. and unred>.

SVll
un
red. red

Rab.
red. red

•%i#*f

Figure 24

Comparison of immunoprecipitated idiotypic

molecules

from

two

different

human T cell leukemias. Tcxdinated extracts of Si cells were
immunoprecipitated with 5150 antibody and run under nonreduced (lane 2) and
reduced (lane 4) conditions. Precipitation of labeled Fi cell lysates with
FF25 antibody is shown nonreduced (lane 1) and reduced (lane 3).
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Figure 25

Yields from sequential hybridization of T cell crDNA to B cell A+ RNA

1st hybridization:
R t:

500
o

percent single stranded:

^1%

percent double stranded:

'^9%

2nd hybridization:
R t:

500

o
percent single stranded:

88%

percent double stranded:

49%

3rd hybridization:

500
percent single stranded:

98%

percent double stranded:

2%

Figure 25

Northern blot analysis of "specific" probe.

"^ ug of T cell and B cell poly

A+ RNA were resolved on a formaldehyde gel, followed by blotting to
nitrocellulose filter paper. And probing with T cell cDNA probe twice
hybridized (selected against) B cell RNA. Markers are indicated in
kilobases.

B

T

^p
kb
4.32.9-

.66.52.28-

•

mP

R

1
1

Figure 77

Screening T cell library with T cell c!i>JA "specific" probe.

Twice

hybrid

depleted T cell cDNA was used to probe nitrocellulose filters cx)ntaining
replicas of a lambda gtIO recombinant phage library from HITT cells. From a
total of 15,000 recombinants, 245 were positive with the selected probe.
An example is seen here of approximately 20 "positive" placjues on a filter
containing approximately 500 total plaques.

0
#

n

Figure 7Q

Testing intactness of Northern

blot

RNAs

giving

rise

to

heterogeneous

patterns. Filter #3 from Figure 28 was washed at high temperature to
remove original probe. Ttie same filter was then probed with a known unique
sequence gene (generously donated by Dr. Hung Teh Kao). Ttie presence of a
clear band in both T and B cell lanes verifies the intactness of both RNA
sources.

Figure 30

Repetetive sequences in T and B cell RNAs. To test

whether

the

patterns

obtained in Figure 28 might be due to repetitive DNA sequences, filter *4
from Figure 28 was washed (reexposed to ascertain removal of the first
probe) and probed with nick translated human gencamic FKA.
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Materials and Methods

Sera, cells, and cell growth. Sm and RNP serological determinations were
carried out by the passive hemagglutination assay described by Tan and
Peebles (1^75). Ttie human myeloid cell line K552 was grown in RPMi 1540

(microbiological Associates, Walkersville, Md.) supplemented with 10% feta
bovine serum (FBS) (Grand Island Biological Co., Grand Island, N.Y.I, 2 mM
glutamine, and antibiotics (ccxnplete medium).

In vivo labeling. Extended labeling was carried out by resuspending washed
5
K552 cells at 10 per ml in methionine-free RPMT i<^4n supplemented with "'0%
FBS, glutamine, and antibiotics as above (met-free medium). To this, o,^
ug per ml of methionine was added together with 100 uCi per ml of Smethionine (800-1000 Ci/mM, New England Nuclear, Boston, Mass.l. Following
incubation for 15 hours, cells were washed three times in ice cold
Dulbecco's phosphate buffered saline (PBS) and lysed. Pulse and pulse-

chase procedures were carried out on cells starved (unless otherwise noted)
for two hours in met-free medium. Methionine-starved cells (usually ^ X
7
10 ) were pelleted and loo ul met-free medium supplemented with 500 uCi
35
• S-methionme was added. Ttie cell suspension was incubated for eight
minutes at 37 c followed by immediate resuspension in 50 ml of ice cold
PBS. In chase experiments, pulsed cells were resuspended in complete
5
medium

at

a density of 10 per ml. TXiring chase, cells were incubated at

37° C and appropriate aliquots were removed, washed in ice cold PBS, and
extracted at the time points listed in the legend to Figure lo.

-12P-

Cell lysis and immunoprecipitation of snRNPs. Following

three washes

in

ice cold PBS, cells were swelled for 10 minutes on ice in 10 mM KCl, 10 m
Tris-Cl (pH 7.5), 5.0 mM iodoacetamide, 0.*^ mM
phenylmethylsulfonyl fluoride, 1.0 mM EDTA. Cells were then lysed by "'2

strokes using a Dounce homogenizer. NaCl was added to 0,2 M and the lysat
was clarified by centrifugation at 17,000 x g for 8 minutes.

Immunoprecipitation of the lysate was carried out by the addition of ^-10
ul of appropriate patient serum p)er immunoprecipitate. Cells were lysed
5 7 5
10 -10

per ml, and each immunoprecipitate

was

derived

from

1-5

X

10

cells. After one hour at 4°c, 40 ul protein A Sepharose 4B (Pharmacia,

piscataway, N. J.) was added and the tubes were rotated for an additional

hour at 4°C. Immunoprecipitates were washed four times with 0,^% NaDodS04
2.5% Triton X-100, 50 mM Tris-Cl (pH 7,5), 0.15 M NaCl, 1.0 mM EDTA, and

0.25 M sucrose followed by two washes with 50 mM Tris-Cl (pH 7.5), o.15 M
NaCl, 1.0 mM EDTA, 1 % trasylol.

RNA extraction methcx3s

The perchlorate extraction methcx3 for isolating total cellular

RNA.

Ttiis

method (Lizardi and Engelberg, 1979) has been used for RNAs prepared for
vitro translation experiments. Washed cells are resuspended in 2.4% SDS,
100 mM NaCl, 7,s mM EDTA, 20 ug/ml polyvinyl sulfate, 25 mM Tris pH 7.4,
and 350 ug/ml proteinase K. Following 15 minute incubation at 77°c, 4 ml

of 3.5 M Na Perchlorate was added to 5 ml of cell lysate. Ttie mixture wa
heated to 50 C until it became clear. Following shearing through a 70
guage needle, 40 ml of EPR reagent was added. EPR is made by mixing i

-1 7 0 -

volume of saturated sodium perchlorate (in water) with 4 volumes
(which

is

also

salt

saturated) .

(5°C).
EDTA,

acids

are

collected

by

EtOH

Ttie EPR reagent is added slowly. Ttie

resulting mixture is incubated at 4°c
nucleic

of

for

30

minutes, and

precipitated

centrifugation at 30onxg for io minutes

The pellet is dissolved in 15 ml 25 mM Tris pH 7.4, 0.7% SDS, 1 mM
and

nucleic acids were reprecipitated by addition of NaCl to O.IP M

and 0.5 volumes isopropanol and incubation at -20°c for 4 hours.
Following an EtOH precipitation step (in the presence of 0.7 M
was

reprecipitated

NaCl)

RNA

in 7.5 M LiCl at o°C for 10 hours. LiCl precipitation

was followed by 3 further Eton precipitations.

The NP-4 0 methcxJ of preparing cytoplasmic RNA.
To a 1.5-2 ml. prewashed and cooled cell pellet, 9 ml. Isohi pH (io mM Tris
pH

8.4,

140

irf^ NaCl,

1.5

mM MgCl^) and i ml. 5% NP-40 is isohi pH are

added, on ice. Following handmixing for 5 minutes, nuclei are
centrifugation

and

the

supernatent

is

extracted

phenol/chloroform (l:i:l), and chloroform (7:1).

RNA

with
is

removed

phenol

(2:1),

precipitated

times in 0.2 M NaCl and 2.5 volumes EtOH.

The Guanidinium/CsCl2 Method of Prep>aring Total Cellular RNA. The
following solutions are used:
GTC Lysis solution:
47.7 gm Guanidinium Ttiiocryanate
10 mL 0.5 M EDTA
10 mL 1 M Tris pH 7,/i

by

7
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7 mL straight 2-mercaptoethanol
H20 to 100 mL

5.7 M CsCl2/ 50 mM EDTA solution:
95 gm CsCl7
10 mL EDTA
H20 to 100 mL

To 1 volume washed packed cells 10 volumes of GTC solution, are added. DNA
is sheared by either vortexing, or passage through a gauge 7o needle.

In an SW40 tube, a 2-3 mL 5.7 M CSC12/ 50 mM ETTA cushion is first poured.

Ttie extract is layered on top of the CsCl2 cushion. Spin at ''5 K at 20 C
for 24 hours. The pellet at the end of the spin consists of cellular RNA.

Top layers are aspirated off the pellet, v^ich is inverted and drained. Th
pellet is dissolved in a convenient volume of H.O and extracted with
phenol:chloroform and chloroform. RNA is recovered by ethanol
precipitation (twice).

Poly A selection
Total RNA is loaded onto an oligo dT cellulose column, preequilibrated in
wash buffer (0.5 M NaCl, 10 mM Tris pH 7.5, 1 mM EDTA, 0.5% SDS). RNA is
reapplied 3-5 times. Column is washed with 20-3o volumes wash buffer and

eluted with 10 mM Tris pH 7.s, l mM EDTA, 0.5% SDS, in as small a volime a
possible. EtOH precipitation is carried out (X3). For more stringent
washing, a 10% formamide wash step may be included.
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Cell free translation system

Preparation of wheat germ extract
550 ml of CCl. and 270 ml of cyclohexane are mixed. 4o gm wheat germ are
added (obtained from local health food store). Following brief stirring,
remove floating embryos onto filter paper under suction. Dry thoroughly
(minimum of one hour). A sephadex G-''5 column (2.5x1 oo cml should be
preequilibrated in a cold room with running buffer (40 mM Hepes pH 7.^^, loo
mM K acetate, 4 mM DTT, 5 mM Mg acetate - adjusted to pH 7.^ with KOH). 5
gm of floated embryos are added to a liquid N cooled mortar to which 7? ml
of homogenization buffer (40 mM Hepes pH "^.5, lOO mM v acetate, 1 mM
!AgAcetate, 2 mM CaCl^, 4 mw DTT - adjusted to pH 7.^ with yn^) are added, ^
ml at a time. Ttie homogenate (paste) is scraped into a Corex tube and spun
at 13,750 rpm using a Sorvall SS'^4 rotor, for 10 minutes, at 4 c. Remove
the yellow lipid (top layer) , decant the extract (supernatent) , and spin it
again as before. Ttie second supernatent is loaded onto the G-75 colimn and
run with the fastest head possible at 4°c. Void volimn contains a white
slurry which has the most activity. Following one last spin as above,
aliquot and quickfreeze (N^).

Translation
The following conditions were optimized for K*^52 A+ RNA, extracted by
perchlorate method.

Wheat germ 40%, "master mix" 40%, A-»- RNA 7-5%. Master mix is composed of:
cv 1 ox Kv
^^EGS 50%, CB
25%, tRNA (7.5 mg/ml> 10%. ^'^EGS consists of TOO mM A T P
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5%, 20 mM GTP 2%, *^oo mM creatine phosphate 8%, i mM io amino acids without
35
methionine
10%,
S-methionine
(10 uCi/ul) 5P%, P mg/ml creatine
1 ox
phophokmase 4%, 1 M D T T 4%.
^CB consists of: 1 M Hepes 77%, 7 M v Ac
37.5%, 0.5M MgAc 2%, O.IM spermidine 7.7%, IM DTT 4%, ddH^O 77,2%.

Immunoprecipitation of in vitro translation products was carried out by

adjusting translation prcx^ucts to 1% Triton x-1oo, o.i M NaCl, 7c; J^M Tri
Cl (pH 7.4), 5.0 mM EDTA, 7.c;% trasylol, 2.5 mg per ml ovalbimin, and 0,1
ug per ml each of antipain, leupeptin, and pepstatin, and addition of 5-io
ul Sm or RNP serum.

Gel analysis. All washed Protein A Sepharose immunoprecipitates were
eluted in 0.25 M sucrose, 2.0% NaDodS04, 0.1 M Tris-Cl (pH "7.4), «^.o mM
EDTA, 0.1 M dithiothreitol, 0.005% bromphenolblue. Following 5 minutes at

100°C, eluates were removed and applied to 15% NaDodS04-polyacrylamide gels
(Fisher, et al., 1982) and run at 25 mA for 14 hours. Gels were stained in

Coomassie Blue and destained, treated with ppo for fluorography (Bonner and
Laskey 1974), and dried prior to autoradiography.

Sucrose gradient analysis
Pulsed and pulse/chased cell lysates were fractionated on 5-70% sucrose

gradients in lysis buffer with the addition of NaCl to 0.2 M. Lysates frcDm
1-2X10 K552 cells were loaded onto precooled gradients and subjected to

simultaneous centrifugation in an SW 50.1 rotor for 7o hours at 4i,noo rpm,
and 4°C. Gradients were fractionated with an automated fractionator (model

185, Instrumentation Specialties Co., Lincoln, Nebraska) and fractions were
immunoprecipitated with sm and PNP sera as above. Sedimentation standards
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were

human hemoglobin (4.2S), IgG (7S) , and catalase ( U S ) . Fractionation

of in vitro translation products was carried out on 5-70% sucrose gradients
in 130 mM K Ac, 3.5 mM DTT, 3 mM MgAc^, 15 mM Hepes, 80 uM spermine. These

gradients were run at 45,ooo rpm for "'S.^ hours, using RNase A (7S>, bovine
serim albumin (4.5S), igG (7S) , and catalase (IIS) as standards. Poly A+

RNA. was fractionated on iO-''0% gradients in 0.5% SDS, 10 mM NaCl, 5 mM Tri
pH 7.4, 0.1 mM EDTA. Sixty micrograms of poly A+ RNA in the same buffer
was heated to 85 C for 2 minutes, cooled on ice, and centrifuged in a
Beckman Sl^MO rotor for 12 hours at 38,000 rpm, at 70^C. Following
automated fractionation, each RNA fraction was twice ethanol precipitated
prior to translation.

Cell fractionation
Pulsed or pulse/chased cells were fractionated by lysis in 10 nf^KCl, io mM
Tris pH 1»^, 5 mM iodoacetamide, 0.*^ mM PMSF, i mM ETTA, for 10 minutes on
ice. Nuclei were pelleted by centrifugation at 17,000 x g for 4 minutes.
Cytosol fractions (supernate) were made o.2 M in NaCl and the nuclear
pellet was extracted for snRNPS by resuspension in lysis buffer containing
0.2 M NaCl for 5 minutes. Ttie nuclear extract was clarified by
centrifugation at 12,000xg for 5 minutes. All procedures were carried out
at 0-4°C. Nuclear and cytoplasmic extracts were immunoprecipitated using
sm and RNP sera, as above.

Proteolytic peptide mapping
Radioactive protein bands were cut out from gels which had been only
briefly stained and destained (total fixing time: less than V2 hour).
Following rehydration in 125 mM Tris pH 5.8, 0.1% SDS, 1 mM EDTA, gel

-174-

slices

were

placed

into

wells of a 70% SDS-polyacrylamide gel (as above

with the addition of 1 mM EDTA to gel buffer) . Chymotrypsin (various
concentrations in loading buffer) was overlaid into the wells, and
electrophoresis was started. When the bromphenolblue was near the end of

the stacking gel, the power was turned off and digestion allowed to procee
for V hour, followed by further electrophoresis through the resolving gel
(Cleveland, et al., 197 7).

Cell surface iodination, extraction, and inmunoprecipitation
Cells were iodinated in the presence of 10 ug lactoperoxidase (Sigma) and
7 125
0.1 U

glucose

oxidase

(Calbiochem) per 5x10

cells and 5 mCi Na

i (New

England Nuclear). Cells were extracted in TO mM Tris pH ^, 0.1^ M NaCl,
0.5% NP-40, 1% trasylol for 70 minutes on ice. Wtiere immunoprecipitates

were to be analyzed nonreduced, cells were extracted in the presence of 50

mM iodoacetamide. Extracts were cleared by centrifugation at 12,00xg for 5
minutes. Protein-A sepharose (PAS) (Pharmacia) beads were coated with
Rabbit anti-mouse Ig antibodies (RAM) (kindly provided by Dr. Nicholas
Chiorazzi). Extracts were precleared by incubation with RAM-PAS for 2

hours. RAM-PAS beads were incubated with mouse monoclonal antibodies for 7
hours, and added to precleared cell extracts. Immunoprecipitation was

carried out for 5-15 hours, and was followed by washing with TO mM Tris pH
8, 0.5% NP-40, 0.15 M NaCl, 1 mM EDTA, 1 mg/ml ovalbumin. Elution and gel
analysis were carried out as described, above.

Recombinant DNA methods;

Synthesis of souble stranded, linker ligated cnNA. Ttie methods employ

-13^-

standard

technologies

(Maniatis)

with

a

few

exceptions. First strand

synthesis was carried out in the presence of actinomycin D. Ttie second
strand reaction was essentially a nick translation utilizing RNase H, e.
coli DNA polymerase I, and e. coli DNA ligase. Following filling ends and
77

methylation,

linker

ligation

was

carried

out

using

P-labeled Eco Ri

linkers. Figure "^l shows an auto radiograph of a gel used to monitor linke
ligation, before and after Eco Rl digestion. Cut linkers were separated
from linker-ligated cDNA using a 1 ml sepharose C1-4B column.

Preparation and ligation of phage DNAs Lambda GTIO and GT11 DNAs are

isolated by phenol extraction from CsCl gradient purified phage (Maniatas).
Dialysis must be carried out because of a ligation inhibitor in the Cs.
Both of these phage systems utilize an Eco Rl site for cDNA insertion. Eco
Rl cleavage is carried out for the purified DNA and monitored by gel
analysis in 0.5% agarose gels (in TE), an example of which is shown in
Figure 32.
The ratio of lambda anns to ds cDNA should be about 5-18ug arms to lOO
ng ds CDNA (2-3x molar excess). Freshly digested arms are mixed with the
CDMA, and ligation is carried out as follows:
8 ul H20 with cDNA and lambda arms
2 ul 5x ligase buffer
1 ul T4 DNA ligase
Incubate at 15 C overnight Success of this ligation reaction may
32
be monitored by testing for the presence of

P-labeled phage-sized DNA on

a 0.5% agarose gel. An example is shown in Figure 33 in which recombinant
cDNA (ligated to phage DNA) is visualized near the origin, as well as
unligated cDNA of smaller size.
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Ttie DNA is now packaged using lysates of

mutant

phage

as described

(Maniatas).

Bacterial strains
In the Lambda GtIO cloning system, two
C500

and

strain,

bacterial

HFL (High Frequency of Lysogeny - a mutant of C500).
all

lysogenize

lambda
into

phage

the

host

containing
strain

an

intact

resulting

background of turbid lysis) during infection.
cDNAs

strains

are

inserted

into

a

repressor

in

no

the

HFL

In the HFL
gene

In this cloning

ds

unique Eco Rl in the lambda repressor. Such
now cause

lysis

strain, and can therefore be propagated using this cell line.

will

lyse

and

Ttie C^oo

upon infection by lambda GTIO regardless of whether the

repressor is intact or not.
plaques

will

system,

Ttiis is also the method by which one selects recombinant phage.
strain

used:

lysis (or a minimal

reccmbinant phage, with an interrupted repressor gene can
in

are

However, recombinant

phage

will

show clear

normal lambda GTIO will show turbid plaques. Using C5oo^ ©ne

can determine the proportion of

recombinant

phage

for

a

given

cloning

experiment.
In the Lambda GTll cloning system, ds cDNA is
galactosidase

gene

via

C500.

expression
repressor
(S100).

Lambda
of

the

B-

Lambda GTll will NOT form plaques on HFL

GTll cx>ntains two mutations v^ich are of importance for

hybrid

(CT«5'')

into

a unique Eco Rl site. Ttiere are no strains which

can select for recombinant phage.
or

inserted

and

galactosidase
an

amber

proteins:

mutation

in

a

temperature-sensitive

a gene required for lysis

Ttierefore, at elevated temperatures, plaques

will

(42° C) , and turbid plaques will form on Le302 at 37° c.

form

on

C50o

Tb determine the

proportion of recombinant phage in a library for a given cloning experiment
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one

plates

the

phage on the bacterial strain Yiooo (which will lyse upon

infection by lambda GTll and does not contain an endogenous galactosidase
gene) using the indicators IPTG and XGAL. One then scores for reccmbinant
phage (clear plaques) or intact phage (blue plaques). 2. Plating
Procedure
For plating onto an 82nm plate the following procedure is used:
Add 1-3 ul phage
200 ul of overnight bacteria
200 ul of 10 mM MgCl7
Incubate for 20 minutes at 77 C
Add 4 ml of soft agarose (Kept at 55 C)
= 1 gm NZamine
0.5 gm yeast extract
0.5 gm NaCl
0.2 gm MgCl2
0.7 gm agarose
100 ml H20 autoclave mix
Pour onto L broth plates

Screening and Northern blot analysis are carried out as described
(Maniatas) . For Northern blots, formaldehyde gels are used. For
screening, DNA probes are generated by nick translation. For expression
vector screening, antibodies are mixed with a solution as follows: 1:iOO
dilution of serum, 20% supernatent frcxn overnight culture of (lysed) gtll
phage-bacteria, 10 mM Tris pH 7.4, 150 mM NaCl, 3% bovine serum albumin.
Filters are incubated with this solution for 1 hour, followed by 5 1^
minute washes in 0.5% NP-40, 10 mM Tris pH 7.4, isn mM NaCL. A last wash
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is carried out in the absence of detergent. Following "* hour incubation in
10 mM Tris pH 7.4, 150 mM NaCl, 7% BSA, containing lo"* cpm per ml i"'2'^
protein A (New England Nuclear) the filters are washed with detergent, as
before.

Figure 31

Linker ligation lac3der. Products of the ligation reaction between cDNA and
Eco Rl linkers are seen in the lane marked "Lig." After digestion with Eco
Rl, moncxneric linkers are seen near the bottom of the gel (7% acrylamide),
72
while

linker

ligated

marked "cut Rl."

( P-

labeled) cDNA is seen at the top of the lane

Figure 72

Fragments generated by digestion of DNA

from

lambda

gtll

with

Eco Rl.

Marker DNA's (M) migrate at 15 and 20 kilobases. Two bands of
approximately 18 and 22 kb are the cleavage products of Eco RT digested
(H/Ri) phage DMA. A third band migrating at 45-5o kb in the 11/Pi lane
represents residual uncut phage DNA.

Figure 33

Diagnostic test for the presence of recombinant DNA

molecules.

Following

ligation of cDNA to RVcut phage, an aliquot is resolved on a o.<;% agarose
gel. On such a gel, unligated cDNA runs as a broad fraction (labeled
"cDNA") v^ereas phage DNA, being so much larger remains near the origin.
77
Since the phage DNA itself had not been

P-labeled prior to ligation,

the

presence of counts in this slow migrating fraction indicates successful
ligation of cDNA to phage DNA.
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